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ABSTRACT 
CLASS I HISTONE DEACETYLASES  
IN LUNG DEVELOPMENT AND REGENERATION 
 
Yi Wang 
Edward Morrisey, Ph.D. 
 
The generation and development of the mammalian lung requires an elegantly 
regulated molecular program to control cell number, lineage specification, as well 
as morphogenetic remodeling. Histone deacetylases (HDACs) are a group of 
critical epigenetic factors that can mediate genome-wide transcriptional 
repression. However, the functional roles of HDACs in lung development and 
regeneration have not been previously characterized. In my dissertation, I utilized 
a series of mouse genetic models, ex vivo and in vitro assays to determine the 
functions of three members of class I HDAC family, HDAC1, HDAC2 and HDAC3 
in lung epithelial development and regeneration. These studies reveal that 
HDAC1 and HDAC2 are redundantly required for the development and 
regeneration of Sox2+ proximal lung endoderm progenitors via regulation of 
Bmp4 and cell cycle inhibitors, while HDAC3 is critical for the alveolar epithelial 
remodeling and spreading during lung sacculation and alveologenesis. These 
findings demonstrate strong evidence for the crucial contributions of HDACs to 
lung development and regeneration, and provide novel insights into potential 
therapeutic directions for human lung diseases.  
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Chapter 1: Introduction and Background 
Summary 
The mammalian lung is a pivotal organ given our absolute dependence on 
oxygen for survival.  Generation and development of such an organ requires an 
elegantly regulated molecular program for controlling cell number, lineage and 
morphology. This intricate process is likely to be controlled by epigenetic factors, 
such as histone deacetylases (HDACs), that have a genome-wide impact on 
gene transcription. Despite the importance of these epigenetic factors, their 
functional roles during lung development and regeneration have not been well 
characterized. In this introductory chapter, I will provide an overview of the 
different stages of mouse lung development, the processes of adult lung 
regeneration and the members of class I HDAC family, with an emphasis on the 
critical questions that remain unexplored regarding these areas. 
 
Stages of mouse lung development 
The mouse lung arises from a population of Nkx2.1+ lung endoderm progenitor 
cells located within the ventral side of the foregut at around embryonic day 9 (E9) 
(1). After lineage specification, this population of cells form a primitive tracheal 
tube and two primordial lung buds that soon become completely separated from 
the dorsal portion of the anterior foregut (or primitive esophagus) (2). Between 
approximately E11 and E15, the two primordial lung buds undergo extensive 
branching morphogenesis to establish the tree-like airway epithelial tubules that 
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are patterned in a proximal to distal fashion (3). This pseudoglandular stage is 
then followed by a canalicular stage (E15-E17) which is marked by generation of 
numerous distal airways with tightly compacted lumens through further branching 
morphogenesis along with early differentiation of proximal epithelial lineages (2). 
Embryonic mouse lung development culminates at the last two days of gestation 
(E17-E19) when these tightly compacted distal airways expand into primitive 
alveolar saccules that are juxtaposed to pulmonary capillaries to prepare for 
postnatal respiration (4). After birth, the gas-exchange surface area continues to 
grow through subdivision of primitive saccules into definitive alveoli by secondary 
septations, a process called alveologenesis (4, 5).  The stages of mouse lung 
development are summarized in the Table 1.1. 
 
Early lung branching morphogenesis 
The highly ramified epithelial tubular network that composes the basic 
architecture of the lung is generated through many rounds of epithelial branching. 
The result of early branching morphogenesis during the pseudoglandular stage is 
the establishment of most of the air-conducting bronchial tree. Previous 
evidences suggest that these morphogenetic processes are remarkably 
stereotyped and genetically hard-wired at this stage (6). A recent study showed 
that the formation of a new domain branch from the epithelial tubule requires the 
thickening of the columnar epithelial cells at the site of new budding to acquire a 
bottle-like shape and this process is controlled by a Wnt/Fzd2-mediated 
molecular cascade (7).  
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Although the detailed morphological events associated with new branch 
formation still remain obscure, the signaling networks that orchestrate epithelial-
mesenchymal interactions during this process has become relatively well 
understood over recent years. The distal buds of a developing lung are not only a 
site for active proliferation and branching, but also a center that mediates the 
epithelial-mesenchymal interactions and integrates the inputs from a myriad of 
regulatory signaling pathways (2).  An example of such a complicated feedback 
interaction involves Fgf10 and Shh. Fgf10 is expressed in the distal lung 
mesenchyme and is critical for inducing the growth of new branches (8). Shh is 
expressed in the distal epithelium, and can repress the Fgf10 expression in the 
mesenchyme in a non-cell autonomous manner. This led to a proposed 
mechanism of new bud formation in which Shh at the bud tips progressively 
reduces Fgf10 expression as a bud grows towards the Fgf10-expressing 
mesenchyme and thereby limiting the size of lung buds (9, 10). Previous studies 
have also revealed that many other signaling pathways as well as transcription 
factors play crucial roles in branching morphogenesis. These include Wnt, Bmp, 
retnoic acid and Nkx2.1 (1, 11-14). The detailed mechanisms of how they 
function in lung branching will not be extensively reviewed here.  
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Proximal-distal patterning of the lung epithelial progenitors during 
branching morphogenesis 
The mature lung is a highly arborized organ whose airway tubules harbor a 
distinct proximal to distal axis. Such an axis is established early on through 
patterning of the lung epithelial progenitor fates during branching morphogenesis. 
Each individual branching bud tip of the developing lung contains a population of 
distal progenitor cells that express markers such as Sox9 and Id2. They are 
multipotent and highly proliferative progenitors actively engaged in forming new 
branches. Whereas only those cells located at the tip front are constantly 
maintaining a distal progenitor fate throughout the new bud outgrowth, most of 
the descendants from distal progenitors will leave the tip zone and begin to 
express proximal progenitor marker Sox2 (15, 16). Through repeated cycles of 
such branching and patterning, these resulting Sox2+ proximal progenitors 
increase in number to construct the future conducting airways. Lineage tracing 
experiments showed that early distal progenitor cells marked by Id2 expression 
are able to give rise to epithelial progenies lining throughout all the airway 
compartments, whereas the descendants of the late Id2+ distal cells are 
restricted to the distal alveolar compartments (17). The proximal distal patterning 
of the embryonic lung during pseudoglandular stage is illustrated in Figure 1.1. 
 
The boundary between the Sox9+ distal compartment and the Sox2+ proximal 
compartment is tightly controlled by several signaling pathways such as Bmp and 
Wnt.  Bmp4 is expressed in the distal tip of the lung bud. When Bmp antagonists 
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were overexpressed in the developing lung epithelium, distal airway development 
was severely inhibited resulting from the expansion of the proximal airway 
compartment (18, 19), suggesting that Bmp signaling can play a role in 
promoting the distal cell fate while suppressing the proximal cell fate. Wnt 
signaling plays a similar role in regulating proximal-distal patterning as targeted 
deletion of β-catenin in the developing lung epithelium led to a lung 
proximalization phenotype (20). Despite the importance of Bmp and Wnt in 
regulating the proximal-distal patterning, the factors that control and coordinate 
these signaling pathways during lung development remains to be identified. 
 
Lung sacculation  
By the end of the canalicular stage (at approximately E16.5), the main structure 
of the respiratory tree, including the entire conducting airway as well as 
numerous compacted distal airways that will develop into future alveoli, has been 
established through branching morphogenesis. The next stages of lung 
development, called lung sacculation and alveologenesis, involve both expansion 
and differentiation of the compacted distal airways into gas-exchanging alveoli, 
which is essential for postnatal respiration. Prior to sacculation, the narrowed 
distal airway tubules are lined with epithelial progenitor cells that are cuboidal in 
shape and express markers such as Sox9 and Id2 (17). By E17.5 a wave of 
airspace expansion and alveolar epithelial differentiation occurs at the broncho-
alveolar junction, which then progresses towards the distal airway tip at E18.5 
(21, 22). This results in the differentiation of two major alveolar epithelial cell 
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lineages: the flat squamous alveolar type I (AT1) cells and the small cuboidal 
alveolar type II (AT2) cells. After specification, AT1 cells spread extensively and 
cover approximately 95% of the alveolar luminal surface while AT2 cells undergo 
maturation to produce surfactant proteins that are essential in reducing alveolar 
surface tension to prevent distal alveoli from collapsing after birth (Figure 1.2).  
 
In contrast to the early lung branching morphogenesis that has been extensively 
explored in recent studies, far less is known about these late lung developmental 
processes. Studies using mouse genetic models suggested that Tgf-β signaling 
might play a crucial role in promoting lung sacculation. Global loss of either Tgfβ2 
or Tgfβ3 caused alveolar hypoplasia including narrowed distal airways and 
thickened mesenchyme (23, 24). Moreover, lung epithelial-specific loss of TgfβRI 
(ALK5) led to perinatal demise associated with a collapsed distal airspace, 
although detailed defects in the distal epithelial development were not explored in 
this study (25). However, it still remains unclear how Tgf-β signaling directs this 
process, and in particular, whether it regulates any type of cellular behavior and 
remodeling during this stage of lung development.  
 
Recent studies have shown that microRNAs might also be critical for lung 
sacculation. The miR-17-92 cluster is highly expressed at early stages of lung 
development and declines as development proceeds (26). Transgenic over-
expression of this cluster in the developing lung epithelium driven by the potent 
Sftpc promoter caused unexpanded distal airways and impaired cell 
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differentiation at E18.5, suggesting that down-regulation of this microRNA cluster 
is required for the proper formation of primitive alveolar saccules (26). However, 
it is not clear what factors control the downregulation of miR-17-92 during lung 
sacculation.  
 
In addition to Tgf-β signaling and miR-17-92, several other factors are also 
implicated in the formation of lung saccules. These include transcription factors 
such as Sox11, FoxM and Gata6, as well as signaling pathways such as 
glucocorticoid signaling (27-30). Most of these studies focused on examining the 
defects in cell proliferation or lineage differentiation of alveolar epithelial cells 
including AT1 and AT2 cells. Although it is well known that lung sacculation 
involves dramatic morphological changes both at the cellular and tissue level, 
there is little understanding about what these morphogenetic events are and how 
they are regulated during this stage of development. 
 
The composition and function of the adult lung epithelium 
The adult mouse lung airway epithelium is composed of a mixture of 
differentiated cell lineages. The pseudostratified proximal airways are derived 
from the aforementioned Sox2+ proximal progenitors during the embryonic stage 
(31, 32). The club cells and multi-ciliated cells are two major luminal cell types 
lining the adult proximal airways including trachea, bronchi and bronchioles. The 
club cells can produce secretory proteins to protect the airway epithelium from 
harmful substance from the environment while the multi-ciliated cells are able to 
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clear the mucus in the conducting airways by sweeping the mucus outward. In 
the major conducting airways, one can also find mucus-producing goblet cells 
and rare neuroendocrine cells lining the airway lumen, along with small basal 
stem cells buried under the luminal cells.  
 
In the distal alveoli, there are two major epithelial lineages--the squamous 
alveolar type 1 cells (AT1) and the cuboidal type 2 cells (AT2). AT1 cells have a 
unique flattened morphology which allows them to cover approximately 95% of 
the gas-exchanging surface. They are extremely thin and closely apposed to the 
pulmonary capillaries to facilitate efficient oxygen diffusion. The cuboidal AT2 
cells can secrete surfactant proteins and lipids to reduce the surface tension and 
contribute to host defense.  
 
Regeneration of adult lung epithelium after injury 
Recent studies suggest that many cell lineages in the adult lung can exhibit a 
considerable amount of plasticity during injury and repair (3).  In the mouse 
proximal airways, club cells have been shown to exhibit stem cell-like functions. 
Lineage tracing results showed that club cells can give rise to multi-ciliated cells 
as well as replenish its own lineage after depletion of airway luminal cells by SO2 
treatment (33, 34). In the model of naphthalene-induced injury in which club cells 
are specifically depleted, the lungs are able to repopulate and restore the 
proximal airways through regenerative processes. Some studies suggest that a 
small subset of club cells are resistant to naphthalene induced cell toxicity and 
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thus can act like a progenitor pool to proliferate and repopulate the bronchioles 
(35) (Figure 1.3). In the upper airways such as trachea and bronchi, the basal 
cells have been shown to function as a source of stem cells in the adult lung and 
can self-renew and generate club cells during injury repair (36). In the distal 
airway, AT2 cells have been shown to proliferate and give rise to AT1 cell during 
homeostasis and in response to injury by lineage tracing experiments (37). In 
contrast, AT1 cells are generally thought to be terminally differentiated. However, 
a recent study suggest that certain AT1 cells may also have some abilities to 
convert to AT2 cells (38).  
 
An overview of class I HDACs 
Histone deacetylases (HDACs) are a group of important epigenetic factors that 
mediate gene repression. One important way to induce gene repression by 
HDACs acts by deacetylating the histones, which compacts the chromatin and 
reduces access of transcriptional regulators (39).  In addition, HDACs have also 
been shown to modulate the acetylation status of some transcription factors 
including p53 and Gata4 to control their transcriptional activities (40, 41). 
Interestingly, recent studies suggested that the enzymatic function of certain 
HDACs might not be critical for gene repression as the deacetylase-dead HDAC3 
could rescue many of the phenotypes seen in the HDAC3-deficient mouse livers 
(42). 
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The mammalian HDAC superfamily consists of 11 members that can be 
classified into four classes. These four classes of HDACs, class I, IIa, IIb and IV 
have distinct structures and functions. In addition, the mammalian genome also 
encodes sirtuins, another group of proteins that contain deacetylation activity (43).  
The class I family of HDACs is composed of four members, HDAC1, HDAC2, 
HDAC3 and HDAC8 (Figure 1.4). They share homology with Rpd3 in the yeast 
and are broadly expressed in the mammalian tissues. All class I HDAC members 
are almost exclusively expressed in the cell nucleus (39). They lack DNA binding 
domains and often rely on their association with transcriptional repressors to 
associate to DNA. HDAC1 and HDAC2 are highly homologous in their protein 
sequences and often found in the same repressive chromatin complexes 
including Sin3A, NuRD, CoREST and PRC2 complexes. HDAC3, in contrast, is 
found in distinct complexes including NCoR and SMRT (44-47). These evidences 
suggest that HDAC1 and HDAC2 may have redundant physiological functions in 
vivo while HDAC3 may play a very different role.  
 
Regulation of cell proliferation, survival and organ development by class I 
HDACs 
A common function of class I HDACs revealed by numerous studies is that they 
play a crucial role in promoting cell proliferation and inhibiting apoptosis (48-50). 
For example, loss of HDAC1 and HDAC2 in B cell lineage led to a block in G1 to 
S transition. This was partially mediated by an up-regulation of cell cycle inhibitor 
p21 (Cdkn1a), which is a direct target of HDAC1 and 2 (50). HDAC3 has also 
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been shown to play a similar role in regulating cell proliferation and survival 
through repressing cell cycle inhibitors (49). In addition to this common function, 
recent mouse genetic studies demonstrated that class I HDACs play tissue-
specific roles in various organ development (48, 51). 
  
HDAC1 and HDAC2 
Global loss of HDAC1 caused early embryonic lethality due to proliferation 
defects and growth retardation (52), while straight deletion of HDAC2 led to 
cardiac malformation (48). Cardiac specific deletion of either HDAC1 or HDAC2 
had no obvious phenotypes, while conditional loss of both genes resulted in 
cardiac arrhythmias, dilated cardiomyopathy, and up-regulation of genes related 
to skeletal muscle contractile proteins and calcium channels (48), suggesting that 
HDAC1 and HDAC2 play redundant functions during heart development. Loss of 
HDAC1 and HDAC2 in the skin impeded hair follicle specification and epidermal 
proliferation and stratification, which resulted from a hyper-acetylated p53 that 
opposed p63 function during epidermal development (51).  
 
Hdac3 
Hdac3 null mice died early at gastrulation (53, 54). Several studies have shown 
that hepatic loss of Hdac3 led to lipid accumulation and decrease in glycogen 
storage (55, 56). Loss of Hdac3 in cardiomyocytes caused a dramatic up-
regulation of lipid storage in the heart (54). Neural crest cell specific deletion of 
Hdac3 resulted in an impairment of smooth muscle differentiation and outflow 
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tract development (57). These genetic studies of Hdac3 revealed that Hdac3 
plays tissue-specific roles that are not overlapping with Hdac1 and Hdac2.  
 
Hdac8 
A previous study showed that global deletion of Hdac8 caused a defect in skull 
formation, which was phenocopied by conditional loss of Hdac8 in cranial neural 
crest cells (58). 
 
Potential functions of class I HDAC members during mouse lung 
development and regeneration 
As mentioned earlier, the class I HDACs play very distinct functional roles during 
organ development and homeostasis. Our preliminary data has shown that 
HDAC1, 2 and 3 are highly expressed in the mouse lung (refer to chapter 2 and 
3). However, what functions the class I HDACs possess during lung development 
and regeneration is not well characterized.  
 
Previous studies in our lab have indicated that the transcription repressors 
Foxp1/2/4 interact directly with the HDAC1/2-containing NuRD complex (59). 
Loss of Foxp1/4 in the developing lung epithelium caused defects in proximal 
airway differentiation (60), leading to our hypothesis that HDAC1 and 2 may 
similarly be important for proximal airway development. Interestingly, decreased 
HDAC2 expression and activity has been associated with the severity of chronic 
obstructive pulmonary disease (COPD) (61), a type of lung disease thought to be 
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related to impaired cell regeneration after repeated injury. This suggests that 
HDAC1 and 2 might also be implicated in the adult lung injury repair as well.  
 
In contrast to HDAC1 and 2, HDAC3 is found in distinct repressive complexes, 
suggesting that HDAC3 may differ in its function during lung development. A 
previous study showed that a global point mutation of SMRT that abrogated its 
interaction with nuclear receptors caused defective lung sacculation and AT1 cell 
differentiation (62). Given the close association to the SMRT complex, we 
hypothesized that HDAC3 may also be important for late lung development.  
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Table 1.1: Stages of mouse lung development 
Stage Embryonic Time Point Description 
Embryonic E9-E11 
Specification of primitive trachea 
and lung bud; Separation of 
trachea and esophagus; First 
few generations of branching. 
Pseudoglandular E11-E15 
Extensive branching 
morphogenesis giving rise to 
most of the proximal airway tree. 
Canalicular E15-E17 
Further branching giving rise to 
distal airways for future alveoli; 
Differentiation of proximal 
epithelium. 
Saccular E17-P3 
Differentiation and expansion of 
distal airway into primitive 
alveolar saccules 
Alveolar P3-P30 Secondary septation formation 
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Figure 1.1: Proximal-distal patterning of early embryonic lung 
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Figure 1.1: Proximal-distal patterning of early embryonic lung 
(A) A diagram illustrates the proximal-distal patterning of the early lung epithelial 
progenitors at E12.5. The green marks the Sox2+ proximal epithelial progenitors 
that will later give rise to differentiated proximal epithelial lineages including club 
cells and ciliated cells. The red marks the Sox9+ distal progenitor cells that can 
give rise to the Sox2+ proximal epithelium during early stages of lung 
development, while only generate the distal alveolar epithelium after E16.5.  
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Figure 1.2: Lung sacculation 
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Figure 1.2: Lung sacculation 
(A) A model diagram describes the process of lung sacculation. Mouse lung 
sacculation starts at approximately E16.5 when the small distal epithelial tubules 
are composed of cuboidal distal progenitor cells. At E17.5, the differentiation of 
these progenitor cells into AT1 and AT2 cells occurs first at the broncho-alveolar 
junction, which then progresses towards the distal airway tip. This is 
accompanied by the expansion of distal airway space at the same time. At E18.5, 
the distal saccules are further enlarged and AT1 cells expand substantially to 
cover the alveolar surface. Yellow marks distal epithelial progenitor cells. Red 
marks the AT1 cells. Green marks the AT2 cells. 
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Figure 1.3: Club cell regeneration after naphthalene injury 
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Figure 1.3: Club cell regeneration after naphthalene injury 
(A) The diagram illustrates the course of club cell regeneration after naphthalene 
injury. The proximal airways of adult lungs are composed of two major luminal 
cell types: the Scgb1a1+ club cells and the TubbIV+ ciliated cells. Naphthalene 
specifically depletes the majority of club cells four days after injury. A small 
subset of the club cells is resistant to injury and can proliferate and repopulate 
the denuded airways. This regenerative process takes around a month to be 
complete.  
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Figure 1.4:  Members of class I HDAC family 
 
 
Adapted from (39) 
 
 
 
  
S S
S S
S
S
HDAC1
HDAC2
HDAC3
HDAC8
Repressive Complexes Global Knockout
NuRD; Sin3A; CoREST; PRC2
Class I HDAC Members
NuRD; Sin3A; CoREST; PRC2
NCoR; SMRT
N/A
Proliferation Defects
Cardiac malformation
Gastrulation Defects
Skull Defects
A
S
Conserved Domain
Serine Phosphorylation Site
	   22	  
Figure 1.4: Members of class I HDAC family 
(A) The Class I HDAC family consists of HDAC1, 2, 3 and 8. The structures of 
these proteins are illustrated as above. The blue rectangles represent the 
homologous regions of these proteins. S represents the serine phosphorylation 
site. HDAC1 and HDAC2 are found together within the same chromatin 
repressive complexes including NuRD, Sin3A, CoREST and PRC2. HDAC3 is 
found in different complexes including NCoR and SMRT. Global loss of these 
proteins in mice caused distinct phenotypes as listed as above. 
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Chapter 2: Regulation of the development and regeneration of 
Sox2+ proximal progenitors by HDAC1/2  
A proportion of this chapter has been published in Developmental Cell (63). 
 
Introduction 
In Chapter 1, I gave an overview of the current concept regarding the proximal-
distal patterning of the epithelial progenitors during early stages of lung 
development.  Although signaling pathways such as Bmp has been implicated in 
inhibiting proximal fate while promoting the distal fate during lung development 
(18, 19), the mechanisms of how these signaling pathways are regulated during 
the process of proximal-distal patterning are poorly understood. Previous studies 
in our lab have shown that FoxP transcription repressors interact with the 
Hdac1/2-containing NuRD complex, and loss of Foxp1/4 in the developing lung 
epithelium resulted in an impairment of lung proximal epithelial differentiation, 
suggesting that Hdac1/2 might play a role in regulating the lung proximal fate.  
 
In this chapter, we show that the development and regeneration of Sox2+ 
proximal progenitors in the lung endoderm is regulated by Hdac1/2. Hdac1/2 
deficiency in the developing lung endoderm leads to a loss of Sox2 expression 
resulting in a block of proximal airway development. This is mediated in part by 
de-repression of Bmp4 and the tumor suppressor Rb1, which are direct 
transcriptional targets of Hdac1/2. In contrast to the developmental stage, 
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postnatal loss of Hdac1/2 in the airway epithelium does not affect the expression 
of Sox2 or Bmp4 in homeostasis. However, in a model of lung airway injury and 
regeneration, postnatal loss of Hdac1/2 leads to up-regulation of the cell cycle 
regulators Rb1, p21/Cdkn1a and p16/Ink4a, resulting in a defect in cell cycle 
progression and disrupted regeneration of Sox2+ lung epithelium. These studies 
show that Hdac1/2 have both common and unique targets that differentially 
regulate tissue specific progenitor activity during development and regeneration. 
 
Results 
Expression pattern of Hdac1/2 during lung development 
To study the requirement of Hdac1/2 for mouse lung development, we started by 
examining the expression pattern of Hdac1/2. We performed 
immunohistochemistry for Hdac1/2 protein on wild type embryonic lung sections 
at various stages of gestation. Starting at E12.5, both Hdac1 and Hdac2 are 
ubiquitously expressed in both endoderm and mesenchyme of the developing 
lung (Figures 2.1A and 2.1D). Hdac1 continues to be broadly expressed at later 
stages of lung development (Figures 2.1B and 2.1C). In contrast, the 
mesenchymal expression of Hdac2 reduces as development proceeds and from 
E18.5 to adulthood, the primary site of Hdac2 expression is proximal airway 
epithelium (Figures 2.1E and 2.1F). In the adult lungs, Hdac2 expression was 
detected in both club cells and ciliated cells of the proximal airways (Figures 
2.1G-2.1J). The high expression levels of Hdac1 and Hdac2 suggest that the 
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both factors may play an important role in regulating the airway endoderm 
development. 
 
Loss of Hdac1/2 expression leads to defective lung branching without 
affecting lung identity 
To determine whether Hdac1/2 is required for lung development, we deleted both 
genes specifically in the foregut endoderm by using the Hdac1flox/flox and 
Hdac2flox/flox alleles and the Shhcre line which efficiently drives Cre recombination 
in the early anterior foregut endoderm at around E8.75 (48,	  64). These mutants 
will now be referred to as Hdac1/2ShhcreDKO. Hdac1 and Hdac2 were efficiently 
deleted in the mutant lung epithelial cells from E12.5 and later as shown by 
immunostaining (Figures 2.2A-2.2F). Hdac1/2ShhcreDKO mutants died immediately 
at birth showing respiratory distress (data not shown). Examination of lungs from 
E17.5 Hdac1/2ShhcreDKO mutants showed a severe loss of branching 
morphogenesis resulting in large dilated sac-like structures (Figures 2.2I-2.2M). 
To assess the chronological onset of these defects, we examined 
Hdac1/2ShhcreDKO and control lungs at E10.5 and E12.5. At E10.5, the trachea of 
Hdac1/2ShhcreDKO mutants had separated from the esophagus and the generation 
of two primordial lung buds had occurred normally (data not shown). However, 
while control lungs had started to branch extensively by E12.5, Hdac1/2ShhcreDKO 
mutant lungs displayed a lack of branching morphogenesis (Figures 2.2G and 
2.2J). The impeded branching morphogenesis persisted to be obvious at E14.5 
(Figures 2.2H and 2.2K). Of note, individual loss of either Hdac1 or Hdac2 did not 
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lead to obvious phenotypes in lung morphogenesis and these mutants were 
viable (data not shown), indicating that Hdac1 and 2 are functionally redundant 
during lung development. 
 
To determine whether tracheal and esophageal specification had occurred 
properly in Hdac1/2ShhcreDKO mutants, we examined the expression of Nkx2.1, an 
early marker for respiratory epithelial specification, and p63, which is 
preferentially expressed in the esophagus at this stage. Supporting the 
histological data, these two proteins are expressed normally in both control and 
Hdac1/2ShhcreDKO mutant embryos (Figures 2.2N and 2.2O). Nkx2.1 continued to 
be expressed in the Hdac1/2ShhcreDKO mutant lung epithelium at E17.5 (Figures 
2.2P and 2.2Q) suggesting that lung epithelial identity is maintained throughout 
development. These data indicate that loss of Hdac1/2 in the lung endoderm 
leads to defects in early lung branching morphogenesis without affecting 
respiratory epithelial specification or tracheal-esophageal separation.  
 
Loss of Hdac1/2 causes a loss of Sox2+ proximal progenitor cells 
To assess the transcriptome changes caused by loss of Hdac1/2 in early lung 
endoderm, microarray analysis was performed on control and Hdac1/2ShhcreDKO 
mutant lungs at E12.5. 149 genes were differentially down-regulated and 70 
genes were differentially up-regulated by more than 1.4-fold in Hdac1/2ShhcreDKO 
mutant lungs. A focused examination of changes in transcription factor gene 
expression showed that the expression level of Sox2 was decreased in 
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Hdac1/2ShhcreDKO mutant lungs (Figure 2.3A). The airways of the developing lung 
are patterned in a distinct proximal-distal fashion with Sox2 marking the proximal 
airway progenitor population which will give rise to the epithelial lineages within 
the conducting airways (31,	  32,	  65-­‐67). Conversely, Sox9 and Id2 mark distal 
endoderm progenitors in the early lung (17). Although Sox9+/Id2+ distal 
progenitors are multi-potent prior to E16.5, their progenitor capacity is restricted 
to generating distal alveolar epithelial lineages after this time point (17)	  (refer to 
Chapter 1 Figure1.1A).  
 
Immunostaining of a series of histological sections from the anterior to posterior 
regions of both control and Hdac1/2ShhcreDKO lungs showed a significant loss of 
Sox2 protein expression at E12.5 (Figures 2.3B and 2.3C). This was confirmed 
by QPCR analysis (Figure 2.3D). At E10.5, a small population of Sox2+ cells was 
observed in the dorsal aspect of the developing trachea in both control and 
Hdac1/2ShhcreDKO mutant lungs, although the number of Sox2+ cells appeared to 
be slightly reduced in the Hdac1/2ShhcreDKO mutants (Figures 2.3G and 2.3J). This 
was likely resulted from the incomplete loss of Hdac1/2 protein prior to E11.5 
possibly owing to the stable nature of Hdac1/2 proteins (Figures 2.3E-2.3I), 
despite the fact that Shhcre driven recombination is observed as early as E8.75 (64). Of note, Hdac1/2 were also efficiently deleted in the developing esophageal 
endoderm in the Hdac1/2ShhcreDKO mutants (Figures 2.3K-2.3N), however, Sox2 
expression did not appear to be affected in the esophagus (Figures 2.3O-2.3P). 
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These data show that Hdac1/2 are required for Sox2 expression in the 
developing lung endoderm but not in the esophagus.  
 
Loss of Hdac1/2 causes an expansion of Sox9+ distal progenitor cells 
To determine whether distal progenitor development was disrupted in the 
Hdac1/2ShhcreDKO mutant lungs, we assessed the expression of distal progenitor 
marker Sox9 by immunostaining. Sox9 expression was expanded throughout the 
Hdac1/2ShhcreDKO mutant airway epithelium (Figures 2.4A and 2.4B). qPCR 
showed that level of Sox9 expression in the whole lung was not significantly 
altered in HDAC1/2ShhcreDKO mutant lungs (Figure 2.4C), possibly due to the 
decreased Sox9 expression on a per cell basis in Sox9+ cells.  Furthermore, 
expression of the distal progenitor marker Id2 was both expanded and increased 
in Hdac1/2ShhcreDKO mutant lungs as shown by both in situ and qPCR (Figures 
2.4C and 2.4D). These data suggest a crucial role for Hdac1/2 in regulating the 
balance between proximal and distal progenitors during early lung development. 
 
Hdac1/2 are required for proximal epithelial lineage differentiation 
Previous studies have established Sox2 as a crucial regulator of proximal 
endoderm lineage identity and differentiation in the lung (31,	  32,	  66,	  68). To 
assess whether Hdac1/2ShhcreDKO mutant lungs exhibited defects in proximal cell 
fate development and differentiation, we examined the expression of early lung 
proximal progenitor markers SSEA1 (also known as Fut4) and Scgb3a2, and 
	   29	  
found both markers decreased in Hdac1/2ShhcreDKO mutant lungs (Figures 2.5A-
2.5D). Later differentiation markers of proximal cell lineages including Scgb1a1 
(club cells), beta-Tubulin IV (ciliated epithelial cells), Pgp9.5 (neuroendocrine 
cells) and Ascl1 (neuroendocrine cells) were all greatly reduced or undetectable 
in Hdac1/2ShhcreDKO mutant lungs (Figures 2.5E-2.5H and 2.5K-2.5N). Goblet cell 
marker Clca3 was not altered in the mutants (Figures 2.5O and 2.5P). In 
contrast, distal lineage markers including T1alpha (alveolar type I cells) and Sftpc 
(alveolar type II cells) were still maintained in the mutant lungs (Figures 2.5E, 
2.5F, 2.5I and 2.5J), suggesting that distal epithelial lineage differentiation is not 
dramatically affected in these mutants.  
 
Loss of Hdac1/2 results in a de-repression of Bmp4 expression 
To investigate how loss of Hdac1/2 in the developing lung epithelium would lead 
to the loss of Sox2+ proxiamal progenitor, we started by examining the 
expression of multiple pathways known to regulate early lung progenitor 
specification and differentiation, with a focus on those that are regulators of 
proximal-distal progenitor differentiation (19,	  64,	  69-­‐75). Among many other 
signaling pathways, Bmp4 expression was the only one to be dramatically up-
regulated in Hdac1/2ShhcreDKO mutants (Figure 2.6A). In situ hybridization showed 
that Bmp4 expression was expanded throughout the early endoderm of 
Hdac1/2ShhcreDKO mutants (Figure 2.6B) instead of being confined to the 
endoderm at the distal tip of the branching airways as observed in the control 
lungs and as has been previously reported (19,	  74). Expression of members of 
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the Wnt and Fgf pathways as well as downstream effectors of these pathways 
were not significantly changed in Hdac1/2ShhcreDKO mutants. Expression of Notch1 
was slightly up-regulated whereas expression of the Notch effector Hes1 was 
slightly down-regulated. However, such minor and inconsistent alterations in 
expression of Notch signaling components suggest that Notch may not be 
responsible for the phenotype seen in Hdac1/2ShhcreDKO mutants.  
 
Exogenous Bmp4 can inhibit proximal fate while promoting distal fate 
during lung development 
Bmp signaling is an important regulator of proximal-distal patterning of the 
developing lung. Inhibition of Bmp signaling through over-expression of the Bmp 
antagonists noggin or gremlin inhibits distal lung development and expands 
proximal lung compartment (18,	  19). How Bmp signaling regulates the balance 
between proximal and distal lung development is obscure and whether it affects 
early progenitor specification, maintenance, or differentiation has not been 
tested. To determine whether increased Bmp4 expression could alter the balance 
between proximal (Sox2+) and distal (Sox9+) lung progenitors, we treated E11.5 
wild type lung explants with exogenous Bmp4 for 48 hours (Figure 2.7A). The 
excessive Bmp4 caused a decrease in both Sox2 expression and the number of 
Sox2+ progenitor cells in the lung explants (Figures 2.7B and 2.7C). We also 
observed a reduction in other proximal cell markers including Scgb3a2 and 
SSEA1 expression (Figure 2.7F). In contrast, the Sox9+ progenitors had 
significantly expanded such that they were observed in the proximal airways of 
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the treated lungs (Figures 2.7D and 2.7E). Moreover, Id2 expression was 
elevated by Bmp4 treatment, consistent with Id2 being a direct target of Bmp 
signaling and a marker for distal lung endoderm progenitors (Figure 2.7F). 
Importantly, these changes in gene expression and spatial localization of Sox9+ 
cells were all similar to what was observed in Hdac1/2ShhcreDKO mutants (Figure 
2.4A), suggesting that increased Bmp4 expression may be responsible for the 
phenotype seen in the Hdac1/2ShhcreDKO mutant lungs. 
 
Previous studies have shown that increased Bmp4 expression increases 
apoptosis in multiple tissues including the lung (76). Hdac1/2ShhcreDKO mutant 
lungs also exhibited an increase in apoptosis from E11.5 through E14.5 as noted 
by increased activated caspase-3 immunostaining  (Figures 2.7G and 2.7H). 
Treatment of wild-type lung explants with exogenous Bmp4 also increased 
apoptosis (Figures 2.7I and 2.7J). As in Hdac1/2ShhcreDKO mutant lungs, this 
increase in apoptosis was not spatially restricted and was observed throughout 
the endoderm of the treated explants (data not shown). 
 
Reducing Bmp4 can partially rescue the loss of Sox2+ progenitors caused 
by Hdac1/2 deletion 
To determine if reducing the dosage of Bmp4 could partially rescue the loss of 
Sox2 expression in Hdac1/2ShhCreDKO mutants, we deleted one copy of Bmp4 in 
the Hdac1/2ShhCreDKO mutants using a floxed allele of Bmp4 (77). We then 
	   32	  
performed immunostaining for Sox2 in the Hdac1/2ShhCreDKO:Bmp4Δ/+ lungs at E12.5. 
While Sox2 expression was not detectable in any of the Hdac1/2ShhCreDKO lungs 
we have examined (n=7), we found that 50% of Hdac1/2ShhCreDKO:Bmp4 Δ/+ lungs 
(n=6) showed partial restoration of Sox2 expression in the bronchi and airway 
epithelium upon deletion of one copy of Bmp4 (Figures 2.8A-2.8F). Epithelial 
apoptosis was also decreased in the Hdac1/2ShhCreDKO:Bmp4 Δ/+ lungs (Figures 
2.8G-2.8J). Overall lung structure, however, was not fully restored although 
additional branched airways were observed (data not shown). These studies 
suggest that Hdac1/2 are required to suppress Bmp4 in the proximal lung 
endoderm to allow for proper airway development. Given the lack of a more 
robust rescue, these data also suggest that additional molecular pathways are 
responsible for some aspects of the phenotype observed in Hdac1/2ShhCreDKO 
mutants. 
 
Bmp4 is a direct target of Hdac1/2 during lung development 
To determine whether Bmp4 was a direct target of Hdac1/2 in the developing 
lung, we performed chromatin immunoprecipitation (ChIP) assays by using 
Hdac1/2 antibodies in E12.5 lungs. These experiments showed robust 
association of Hdac1/2 to the proximal promoter region of Bmp4 (Figures 2.9A 
and 2.9B). In contrast, Hdac1 and Hdac2 association was not observed in an 
unrelated intergenic region 1.5 megabases upstream of the Bmp4 locus (Figure 
2.9A). Lung epithelial cell line MLE12 were transfected with either Hdac1/2 
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siRNA or control siRNA to knockdown Hdac1/2 (Figure 2.9C). The acetylation 
level of Histone 3 Lysine 9 (H3K9) was increased at the Bmp4 promoter after 
knockdown of Hdac1/2 (Figure 2.9D), while an unrelated intergenic region 
upstream of Bmp4 was not affected (Figure 2.9E). Similarly, lung explants 
treated with HDAC inhibitor TSA showed an increase in H3K9 acetylation at 
Bmp4 promoter (Figure 2.9F) without altering the acetylation level at the 
intergenic region (Figure 2.9G). Collectively, these studies suggest that Bmp4 is 
a direct target of Hdac1/2 in the developing lung and its de-repression leads to 
down-regulation of Sox2 expression, expansion of Sox9+/Id2+ progenitors, and 
increased endoderm apoptosis. 
 
Endoderm progenitor proliferation is mediated in part by Hdac1/2 
repression of Rb1 
Previous studies have shown that a common effect of the combined loss of 
Hdac1/2 expression is decreased cell proliferation coupled with increased 
apoptosis (48,	  51,	  78). Given that Hdac1/2ShhcreDKO mutant lungs were smaller in 
size compared to control lungs, we examined cell proliferation in these mutants. 
phospho-histone H3 staining showed that epithelial proliferation was significantly 
reduced in Hdac1/2ShhcreDKO mutant lungs (Figures 2.10A and 2.10B). This 
decrease in proliferation was uniform throughout the mutant lungs (Figure 
2.10A). Several important cell cycle inhibitors including p16/Ink4a and 
p21/Cdkn1a have been shown to be direct targets of Hdac1/2 mediated 
repression (50,	  52,	  79,	  80). Notably, loss of p16/Ink4a or p21/Cdkn1a did not 
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rescue Hdac1/2 mediated inhibition of cell proliferation, suggesting the presence 
of additional targets of Hdac1/2 in regulating cell cycle progression (80). 
Therefore, we re-examined our microarray data for any changes in the 
expression of cell cycle regulators in Hdac1/2ShhcreDKO mutants. In addition to 
increased expression of p21/Cdkn1a, we observed an up-regulation of the tumor 
suppressor retinoblastoma-1 (Rb1) in Hdac1/2ShhcreDKO mutant lungs (Figure 
2.10C). qPCR and immunostaining confirmed that Rb1 along with p16/Ink4a and 
p21/Cdkn1a were all elevated in Hdac1/2ShhcreDKO mutant lung epithelium 
(Figures 2.10D-2.10J). p57, another cell cycle regulator that has been reported to 
be a direct target of Hdac1/2, was not up-regulated in the Hdac1/2ShhcreDKO 
mutant lungs and was not expressed at significant levels in the control lungs 
(data not shown and (50)).	   
 
We next tested whether Rb1 was a direct target of Hdac1/2 mediated repression 
in the developing lung. ChIP assays showed that Hdac1/2 is associated robustly 
to the proximal promoter of Rb1 (Figures 2.10K and 2.10L). Knocking down 
Hdac1/2 or treating lung explants with TSA increased H3K9 acetylation at the 
Rb1 promoter (Figures 2.10M and 2.10N). Together, these data indicate that 
Hdac1/2 are required to suppress Rb1 expression to allow for proper proliferation 
of early lung endoderm. Thus, Hdac1/2 are potent regulators of lung progenitor 
proliferation by targeting multiple cell cycle inhibitors in the developing lung 
including Rb1, p16/Ink4a, and p21/Cdkn1a. 
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Hdac1/2 are not required for the homeostasis of lung airway epithelium 
The effects of chromatin remodeling complexes and epigenetic regulation on 
tissue regeneration are poorly understood. Given the potent and specific roles for 
Hdac1/2 in regulation Sox2+ proximal endoderm progenitor development in the 
anterior foregut, we tested whether these factors were important for proximal 
airway epithelial homeostasis and regeneration in the postnatal lung. We 
generated Hdac1/2Scgb1a1creDKO mutants using an Scgb1a1cre line which is active 
in the club cells of proximal airway epithelium beginning at birth (60). Hdac1/2 
were efficiently deleted in Hdac1/2Scgb1a1creDKO lungs as shown by 
immunostaining on the eight-week old mutant lungs (Figures 2.11A-2.11D). In 
contrast to deletion of Hdac1/2 during development, loss of Hdac1/2 in proximal 
airway epithelium did not dramatically affect postnatal airway epithelial 
homeostasis as noted by the normal appearance of the airway epithelium and 
unchanged markers for club and ciliated epithelial lineages in 
Hdac1/2Scgb1a1creDKO mutants (Figures 2.11E-2.11M). Proliferation and apoptosis 
was also not significantly altered in Hdac1/2Scgb1a1creDKO mutants (data not 
shown). Importantly, expression of Sox2, which is expressed in the postnatal 
proximal airway epithelium including the club cells, was not altered in the 
Hdac1/2Scgb1a1creDKO mutant lungs (Figures 2.11G, 2.11K, 2.11M). Thus, Hdac1/2 
are not required for postnatal airway epithelial cell homeostasis. 
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Hdac1/2 are required for regeneration of lung airway epithelium after injury 
The lung has a remarkable capacity to regenerate epithelial lineages including 
the club cells within the proximal airways after injury. To determine whether 
expression of Hdac1/2 were required for airway epithelial regeneration, we used 
a model of airway club cell depletion caused by naphthalene exposure. 
Naphthalene injury depletes the majority of airway club cells (also called Clara or 
secretory cells) in the postnatal lung. The airway epithelium will regenerate 
through a process involving the proliferation of a small subset of naphthalene-
resistant club cells often referred to as facultative airway progenitors (81) (refer 
to Chapter 1 Figure 1.3). Hdac1/2Scgb1a1creDKO mutant and Scgb1acre control mice 
were injected with naphthalene and the epithelial regeneration process was 
assessed at multiple time points by using immunostaining and qPCR for 
Scgb1a1 (club cells), beta-Tubulin IV (ciliated cells), and Sox2 which marks both 
club cells and a large proportion of ciliated cells in the adult airway. Four days 
after injury, the majority of club cells in both Hdac1/2Scgb1a1creDKO and control 
lungs were depleted as shown by the dramatic reduction in Scgb1a1 and Sox2 
expression (Figures 2.12A-2.12D). Ten days after injury, while a significant 
recovery in the number of club cells was observed in Scgb1a1cre control lungs, 
Hdac1/2Scgb1a1creDKO mutants exhibited a dramatic block in the regeneration of 
Scgb1a1+/Sox2+ club cells (Figures 2.12E and 2.12F). Examination of 
Hdac1/2Scgb1a1creDKO mutant lung airways using H&E staining showed that they 
lacked extensive repopulation of club cells ten days after injury, in contrast to 
control airways which had begun to repopulate with club cell epithelium. These 
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alterations in Scgb1a1+/Sox2+ cells were also observed at one month after injury 
suggesting that the loss of regeneration was not transient (Figures 2.12G and 
2.12H).  Beta-tubulin IV expression showed a slight decrease in ciliated cells in 
the mutant lungs by qPCR at ten days post-injury and normal expression level at 
1 month, consistent with the fact that naphthalene specifically depletes the club 
cell lineage (Figures 2.12G and 2.12H). Goblet cell metaplasia has been shown 
to be associated with chronic human lung diseases such as chronic obstructive 
pulmonary diseases (COPD). However, we found that goblet cell markers 
Mucin5ac and Agr2 were not changed in the Hdac1/2Scgb1a1creDKO mutant lungs 
prior to or during the regeneration process (Figures 2.12I and 2.12J).  
 
Hdac1/2 repress cell cycle inhibitors to allow airway regeneration after 
injury 
Given the critical roles of Hdac1/2 in regulating Bmp4 expression and cell cycle 
progression during lung development through repression of Rb1, p16/Ink4a, and 
p21/Cdkn1a, we assessed whether Hdac1/2 regulated these cellular pathways 
during adult regeneration. qPCR and in situ hybridization did not reveal changes 
in Bmp4 expression in HDAC1/2Scgb1a1creDKO lungs (Figure 2.13A). In contrast, 
proliferation of regenerating airway epithelium of Hdac1/2Scgb1a1creDKO mutant 
lungs was significantly compromised during the course of regeneration, 
especially between day 4 and day 10 post-injury when the naphthalene resistant 
facultative progenitors expand to regenerate the airway epithelium (Figures 
2.13B and 2.13C). This decrease in proliferation was associated with an increase 
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in the cell cycle inhibitors Rb1, p21/Cdkn1a, and p16/Ink4a at day 7 after injury 
(Figures 2.13D-2.13I). Of note, expression of these genes was not altered in 
HDAC1/2Scgb1a1creDKO lungs prior to injury (Figures 2.13J-2.13O), suggesting that 
Hdac1/2 regulation of Rb1, p21/Cdkn1a, and p16/Ink4a is only re-activated 
during the regeneration process. These data indicate that Hdac1/2 regulate lung 
endoderm development and regeneration through their differential repression of 
Bmp4 and the cell cycle regulators Rb1, p16/Ink4a, and p21/Cdkn1a.  
Decreased HDAC1/2 expression and increased RB1 expression in human 
COPD samples 
A previous study has suggested an association of decreased HDAC expression 
with the severity of COPD in humans (61,	  82). Given the importance of HDAC1/2 
in controlling adult mouse lung regeneration, we determined whether the 
HDAC1/2-RB1 regulatory pathway is relevant in the human samples. In 
comparison to normal human lungs, immunostaining showed that there was a 
loss of HDAC1/2 expression in the human COPD lungs (Figures 2.14A-2.14D). 
Intriguingly, the cell cycle inhibitor RB1 was highly expressed in the human 
COPD lung epithelium whereas it was only sparsely expressed in the normal 
human lungs (Figures 2.14E and 2.14F), suggesting that cellular proliferation in 
response to injury might be significantly impaired in COPD lungs. Together, 
these data indicate that our observation that Hdac1/2 repress cell cycle inhibitors 
to allow for mouse lung airway regeneration might be applicable to human lung 
diseases, and could provide insights to potential new targets for COPD therapies. 
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In summary, our results in this chapter revealed a differential role for Hdac1/2 in 
in the development and regeneration of Sox2+ proximal lung progenitor cells. 
During mouse development, Hdac1/2 are required for the development of Sox2+ 
progenitors through repressing Bmp4 and cell cycle inhibitors, while during 
regeneration, cell cycle inhibitors but not Bmp4 appear to be the target of 
Hdac1/2 responsible for the regeneration of Sox2+ progenitors (Figure 2.15A). 
Moreover, we show that a decrease in Hdac1/2 expression and an increase in 
Rb1 expression are associated with human COPD samples, further supporting a 
potential regulatory role of Hdac1/2 during the pathogenesis of this disease. 
 
Discussion 
In this chapter, I have shown that the expression of the critical transcription factor 
Sox2 is regulated in the anterior foregut through the chromatin remodeling 
factors Hdac1/2. Development of the proximal Sox2+ endoderm progenitors in 
the lung requires Hdac1/2 expression via regulation of Bmp4 signaling as well as 
cell cycle progression through Rb1, p16/Ink4a, and p21/Cdkn1a. De-repression 
of Bmp4 expression leads to loss of Sox2+ proximal endoderm progenitors in the 
lung along with the subsequent failure to form the proximal airways during 
development. In contrast to development, Hdac1/2 regulate regeneration of 
Sox2+ airway club cells through repression of a cell cycle program including Rb1, 
p16/Ink4a, and p21/Cdkn1a without affecting Bmp4 expression. These studies 
show that Sox2+ endoderm progenitors are regulated by both common and 
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distinct Hdac1/2 mediated pathways during development and postnatal tissue 
regeneration.  
 
Sox2+ is a critical transcription factor important for tissue specific progenitors in 
multiple organs. In the lung, Sox2 is essential for development of the entire 
proximal airway epithelial lineage repertoire. Despite its criticality, little is 
understood about how Sox2 expression is initiated or maintained during 
development. Our finding that Hdac1/2 regulates Sox2 expression in the proximal 
airway epithelium of the developing respiratory system but not the esophagus 
suggests that its expression is differentially regulated in a tissue specific fashion. 
This may be due to the unique requirements of Bmp signaling activity in the 
anterior foregut endoderm. Previous studies have shown that Bmp signaling is 
necessary for initial development of the trachea and that signaling activity inhibits 
Sox2 expression (69). How this precise activity is initiated and maintained has 
been unclear but our data now show that inhibition of Bmp4 expression allows for 
the proper development of the proximal component of the respiratory system. In 
this manner, we postulate that Hdac1/2 act as critical repressive chromatin 
remodeling factors for establishing proximal lung progenitor cell fate, in part, 
through inhibition of Bmp4. 
 
Additional evidence indicates that Bmp4 may be a nodal point for HDAC 
mediated repression and regulation of tissue development through Sox2 
expression. Trichostatin A, an inhibitor of class I HDACs, increases Bmp4 
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expression in limb bud explants (83). Moreover, Increased Bmp4 expression 
leads to decreased Sox2 expression in the neural tube (84). The specific effect 
that loss of Hdac1/2 have on the proximal component of the respiratory system 
without apparent effects on esophageal development may be due to this unique 
targeting of Bmp4 signaling.  
 
Hdac1/2 have been shown to regulate cell cycle progression through de-
repression of p16/Ink4a and p21/Cdkn1a (50,	  80). However, given the potent 
inhibition of cell proliferation often observed upon loss of Hdac1/2 in multiple 
tissues including the lung as well as the inability of loss of p16/Ink4a and 
p21/Cdkn1a to reduce Hdac1/2 mediated inhibition of cell proliferation, additional 
factors are likely involved (Wilting	  et	  al.	  2010). Our studies have identified Rb1 as 
a novel target of Hdac1/2 in the regulation of the cell cycle in lung endoderm. 
Rb1 is a well-known tumor suppressor whose aberrant silencing is closely 
associated with lung cancer (85,	  86). Rb1 and Hdac1 have been reported to 
physically interact (87,	  88), but whether Rb1 was a direct transcriptional target of 
HDAC activity was previously not known. Our studies demonstrate that Rb1 is a 
direct target of Hdac1/2 mediated repression and that its de-repression is 
associated with decreased proliferation. Unlike Bmp4, Rb1 is also up-regulated in 
Hdac1/2-deficient postnatal lung epithelium during the process of lung epithelial 
regeneration. This increased expression of Rb1 and other cell cycle inhibitors, 
including p16/Ink4a and p21/Cdkn1a, leads to a dramatic inhibition of the 
regenerative capacity of the airway epithelium after naphthalene-induced 
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depletion. Our results suggest that Bmp4 is a unique target of Hdac1/2 during 
lung development, whereas Rb1-mediated cell cycle inhibition is a common 
Hdac1/2-regulated pathway that is shared during both lung development and 
regeneration. 
 
The potent role for Hdac1/2 in regulating airway epithelial regeneration is 
interesting in light of recent findings showing that decreased HDAC activity, and 
in particular HDAC2 expression, is associated with the severity of disease in 
COPD patients (61,	  82). COPD is a spectrum of lung diseases that is 
represented by progressive lung airway obstructions caused by environmental 
irritants such as tobacco smoking. Although cigarette smoke-triggered 
inflammation has received much attention on the cellular and molecular 
mechanisms of COPD, the inappropriate airway repair and regeneration after 
repeated insults by smoking is also thought to play an important role. Exposure 
to cigarette smoke can induce cellular senescence in the mouse lung (89,	  90), 
suggesting the potential role of impaired cell proliferation in response to airway 
injuries in the progression of the disease. Our findings indicate that Hdac1/2 act 
to allow for the proper reactivation of cell cycle progression in the regenerating 
airway epithelium after injury through repression of Rb1 as well as other cell 
cycle regulators including p16/Ink4a and p21/Cdkn1a. Consistent with our mouse 
data, we observed an association of decreased HDAC1/2 expression and 
increased RB1 expression in the human COPD lung epithelium. Thus, our data 
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suggest that small molecule therapies that alter the balance of histone 
acetylation may prove useful in treatment of lung diseases such as COPD.  
 
Methods and Materials 
Animals 
Generation and genotyping of Hdac1flox, Hdac2flox, Shhcre, Scgb1a1cre, and 
Bmp4flox alleles have been previously described (48,	  60,	  77,	  91). For qPCR, 
Shhcre and Scgb1a1cre heterozygous mice were used as controls. For embryonic 
histological studies, Shhcre:Hdac1flox/+:Hdac2flox/+ were used as control samples. 
For adult histological studies, Scgb1a1cre were used as controls.  
 
Microarray Analysis 
RNA was isolated from E12.5 lungs from Shhcre control and Hdac1/2ShhCreDKO 
embryos. For each sample, six lung buds were collected and pooled. The RNA 
was then used to generate a biotinylated cRNA probe library for Affymatrix 
Mouse Gene 1.0ST array. Microarray data were analyzed using the Oligo 
package available at the Bioconductor website (www.bioconductor.org). The raw 
data were background-corrected by the Robust Multichip Average (RMA) method 
and then normalized by an invariant set method. Differential gene expression 
between the control and mutant mice was analyzed by the Limma package 
available at the Bioconductor website. P-values obtained from the multiple 
comparison tests were corrected by false discovery rates. Heatmap displays 
were created using the freely available MeV package ( http://www.tm4.org/mev/).  
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Histology 
Tissues were fixed in 4% paraformaldehyde (PFA) overnight, dehydrated with 
ethanol, and embedded in paraffin for sectioning. The following antibodies and 
concentrations were used for immunohistochemistry on paraffin sections:  Hdac1 
(Cell Signaling, 1:50), Hdac2 (Zymed, 1:20), p63 (Santa Cruz, 1:10), Nkx2.1 
(Santa Cruz, 1:50), Sox2 (Seven Hills, 1:500), Sox9 (Santa Cruz, 1:100), SSEA1 
(Millipore, 1:100), Scgb1a1 (Santa Cruz, 1:20), SPC (Chemicon, 1:500), TubbIV 
(BioGenex, 1:20), p-Histone 3 (Cell Signaling, 1:200), Ki67 (Santa Cruz 1:25), 
Rb1 (BD Pharmingen, 1:50), p21 (Santa Cruz, 1:100), p16 (Santa Cruz, 1:100), 
Mucin5ac (Abcam, 1:100).  For whole mount staining, lungs were fixed in 4% 
PFA overnight and dehydrated in methanol. Lungs were then blocked by 5% goat 
serum and stained for E-Cadherin (Sigma, 1:500). 
 
Quantitative PCR 
Total RNA was isolated from lungs at indicated time points using RNeasy Mini Kit 
(Qiagen). cDNA was synthesized from total RNA by using SuperScript Strand 
Synthesis System (Invitrogen). Quantitative PCR was performed using the SYBR 
green system (Applied Biosystems) with primers listed in the Supplemental Table 
2.1. GAPDH expression values were used to control for RNA quality and 
quantity. 5-6 lungs were used for each embryonic lung qPCR experiment and 3-5 
lungs were used for each adult lung qPCR experiment. 
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ChIP Assays 
For ChIP assay on Hdac1/2 antibodies, at least 15 E12.5 lung buds were 
dissected and cross-linked by 3.7% formaldehyde. Cross-linked tissue was 
sonicated to obtain genomic DNA fragments between 200-400bp. Chromatin was 
prepared using a ChIP Assay Kit (Millipore). ChIP antibodies (Hdac1 and Hdac2, 
Abcam) were used to precipitate the Hdac1/2 bound regions, which was then 
detected and quantified by PCR and qPCR with primers listed in Supplemental 
Table 2.1. Rabbit IgG was used as a negative control antibody in these assays. 
The region of the Bmp4 promoter corresponds to approximately 400 bp upstream 
of the transcriptional start site while the region of the Rb1 promoter corresponds 
to approximately 700 bp upstream of the Rb1 transcriptional start site. For ChIP 
assays using H3K9 acetylation antibodies (Abcam), MLE12 cells were 
transfected with control or Hdac1/2 siRNA for 48 hours; E11.5 Lungs were 
cultured with or without 50nM TSA for 24 hours. 
 
Lung Explant Culture 
E11.5 lung buds were dissected from the embryos and then cultured as 
previously described (92)	  in the presence of either 500ng/µL recombinant Bmp4 
or BSA medium for 48 hours. The lung buds were then fixed in 2% PFA for 
histology or stored for RNA extraction. For ChIP assays on H3K9 acetylation, 
E11.5 lung explants were cultured with or without 50nM TSA for 24 hours and 
were crosslinked by formaldehyde before ChIP.  
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Naphthalene Injury 
Adult mice of 8-10 weeks old were injected intraperitoneally with 250mg/kg body 
weight of naphthalene dissolved in corn oil as previously described (60). At 
indicated time points after injection, the right lung lobe was collected for RNA 
extraction and left lobes were inflation fixed with 10% formalin for histological 
sections. Scgb1a1cre mice were used as control mice.  
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Table 2.1: Primer sequences 
 
qPCR Primers 
Genes Forward Reverse 
Axin2 CAGCCCTTGTGGTTCAAGCT GGTAGATTCCTGATGGCCGATGT 
Bmp4 CCCTTTCCACTGGCTGATCA GGGACACAACAGGCCTTAGG 
Fgf10 TGATGCAAAGGTTATCTGCACAT GAGAGTTGCACTTCATACCAAATTTC 
Fgf9 TTCATGCGGTGGGTTCTTATT TCCTCATCCAAGCTTCCATCA 
Fgfr2 GCTTCTCAGTGAGTTTTAATAACAGC GAATGATGCTGGGCTTTTGC 
GAPDH GCCCTTCCACAATGCCAAAG ATCACCATCTTCCAGGAGCGAG 
Hes1 AAAGCCTATCATGGAGAAGAGGCG GGAATGCCGGGAGCTATCTTTCTT 
Id2 GCCACAGAGTACTTTGCTATCATTCG ACCCTGAACACGGACATCAGCAT 
Notch1 TTGAGATGCTCCCAGCCAAGT AGGATTGGAGTCCTGGCATCGTT 
p21 TTGTACAAGGAGCCAGGCCAAGAT ACTAAGTGCTTTGACACCCACGGT 
Rb1 ACCCGATCATGTCAGAGAAAGAGC TGCTGCGATAAAGATGCAGATGCC 
Scgb1a1 ATACCCTCCCACAAGAGACCAGGATA ACACAGGGCAGTGACAAGGCTTTA 
Scgb3a2 GCTGGTATCTATCTTTCTGCTGGTG ACAACAGGGAGACGGTTGATGAGA 
Sox2 TGCACATGGCCCAGACTA TTCTCCAGTTCGCAGTCCAG 
Sox9 CGGCTCCAGCAAGAACAAG GCGCCCACACCATGAAG 
SSEA1 ACTCGTGGACGCCACATGGAGA AGCAGATGAAGGTGGTCAACGC 
TubbIV AACCCGGCACCATGGACTCTGT TGCCTGCTCCGGATTGACCAAATA 
Wnt2 TCTTGAAACAAGAATGCAAGTGTCA GAGATAGTCGCCTGTTTTCCTGAA 
Wnt7b GGATGCCCGTGAGATCAAAA CACACCGTGACACTTACATTCCA 
 
 
ChIP Primers 
Region Forward Reverse 
Bmp4 TCACAGCCTGTTTCAACGTTTGGG AAATACCCATGGGAGTCTGGGCTT 
Rb1 TTGGTGGCGGTAGGTAGTTCTAGT CACGATCCGGCCTCCTTTCATAAT 
Bmp4 
(QPCR) TACGGAAGGCCACCCTTTAAACCA AAATACCCATGGGAGTCTGGGCTT 
Rb1 
(QPCR) GTCGGCGACATGGTCAGACAAATA CACGATCCGGCCTCCTTTCATAAT 
Intergenic 
Region TCTGAGCTACAGACCGGCATTTGT 
AGGAACACAGCCAGATGTTGAGG
A 
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Figure 2.1: The expression pattern of Hdac1/2 during lung development 
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Figure 2.1: The expression pattern of Hdac1/2 during lung development  
(A-C) Hdac1 is expressed broadly throughout the lung endoderm and 
mesenchyme from E12.5 through E17.5.  
(D-F) Hdac2 is initially expressed in both lung endoderm and mesenchyme at 
E12.5 (D), but becomes progressively restricted to proximal airway epithelium by 
E17.5 (arrows in E and F). 
(G-I) Co-staining for Hdac2 and club cell marker Scgb1a1 shows that club cells 
express Hdac2 in the adult lung (arrows). 
(J) Co-staining for Hdac2 and ciliated cell marker TubbIV shows that ciliated cells 
express Hdac2 in the adult lung (arrows). 
Dotted lines outline the developing lung epithelium. BV=blood vessel. Scale bars: 
I and J=10µm. 
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Figure 2.2: Loss of Hdac1/2 in the developing lung epithelium leads to a 
block of branching morphogenesis without affecting lung specification 
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Figure 2.2: Loss of Hdac1/2 in the developing lung epithelium leads to a 
block of branching morphogenesis without affecting lung identity 
(A-F) Hdac1/2ShhcreDKO mutants lack epithelial expression of Hdac1 and Hdac2 
from E12.5 through E17.5 (arrowheads). Dotted lines outline the developing 
airway epithelium.  
(G-M) In comparison to control littermates (M-O), Hdac1/2ShhcreDKO mutants 
display defects in airway branching as exhibited by formation of cysts in the lung 
at E12.5 (J) and these cysts expand in later development resulting in an overall 
smaller lung (arrowheads in K and L).  
(N-Q) Hdac1/2ShhcreDKO mutants maintain proper lung and esophagus 
specification as noted by Nkx2.1 (arrowheads) and p63 (arrows) immunostaining 
at E11.5 (N and O). Lung endoderm identity is maintained through development 
as noted by continuous expression of Nkx2.1 (P and Q).  
BV=blood vessel; E=esophagus; T=trachea. Scale bars: D, E, F, O and Q 
=20µm; J, K and L=40µm.  
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Figure 2.3: Loss of Hdac1/2 in the developing lung epithelium causes a loss 
of Sox2+ proximal lung progenitors 
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Figure 2.3: Loss of Hdac1/2 in the developing lung epithelium causes a loss 
of Sox2+ proximal lung progenitors 
(A) The heatmap generated from microarray results shows differential expression 
of 42 transcription factors in the Hdac1/2ShhcreDKO mutants compared to Shhcre 
controls including Sox2. 
(B-D) Immunostaining of sections throughout the anterior to posterior regions of 
the lung shows that Hdac1/2ShhcreDKO mutants have a dramatic loss of Sox2 
expression at E12.5 (B). The schemes in C demonstrate the approximate 
positions of cross-sections along the anterior-posterior axis of the lung buds.  
The green color outlines the Sox2 expression pattern in control and 
Hdac1/2ShhcreDKO mutants. qPCR result confirms the loss of Sox2 expression in 
Hdac1/2ShhcreDKO mutants at E12.5 (D). 
(E-J) Immunostaining of Hdac1/2 in the E10.5 lungs shows that expression of 
Hdac1/2 protein is still observed in Hdac1/2ShhcreDKO mutants at this time stage (E, 
F, H and I). At E10.5, a small number of Sox2+ cells were observed in the dorsal 
aspect of the developing trachea in both control and Hdac1/2ShhcreDKO mutant 
lungs, although the number of Sox2+ cells appeared reduced in the 
Hdac1/2ShhcreDKO mutants (F and J, arrows). 
(K-P) Immunostaining shows that Hdac1/2 are also efficiently deleted in the 
esophagus of Hdac1/2ShhcreDKO mutants (K-N). However, Sox2 expression is not 
lost in the primitive esophageal epithelium (arrows in O and P) 
Scale bars: B, J and P=20µm; I and N=40µm. 
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Figure 2.4: Loss of Hdac1/2 causes an expansion of Sox9+ distal progenitor 
cells 
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Figure 2.4: Loss of Hdac1/2 causes an expansion of Sox9+ distal progenitor 
cells 
(A-C) Hdac1/2ShhcreDKO mutants have expanded Sox9 expression throughout the 
dysmorphic airways (arrowheads in A) and this is illustrated in B. qPCR shows 
that while overall expression levels of Sox9 are unchanged, expression of the 
distal progenitor marker Id2 is increased in Hdac1/2ShhcreDKO mutants (C). 
(D) In Situ hybridization of distal progenitor marker Id2 further shows that the 
distal progenitor fate has expanded throughout the Hdac1/2ShhcreDKO mutant lungs 
(arrows), similar to the expression pattern of Sox9. 
Scale bars: A=20µm; D=40µm. 
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Figures 2.5: Hdac1/2 are required for proximal epithelial differentiation 
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Figures 2.5: Hdac1/2 are required for proximal epithelial differentiation 
(A-H) Expression of the early proximal epithelium marker SSEA1 (Fut4), 
secretory epithelium lineage markers including Scgb3a2 and Scgb1a1, and 
markers of the ciliated epithelial lineage including TubbIV (arrows in controls) are 
lost or severely decreased in Hdac1/2ShhcreDKO mutants (A-H). In contrast, 
expression of the alveolar type 2 cell marker Sftpc is still noted in 
Hdac1/2ShhcreDKO mutants (F). White dotted lines mark the boundary between 
epithelium and mesenchyme.  
(I-P) T1-alpha, a marker for type I alveolar epithelial cells in the distal epithelium 
is unchanged in the Hdac1/2ShhcreDKO mutant lungs at E17.5 (I and J). Markers for 
neuroendocrine lineages in the proximal epithelium including Pgp9.5 and Ascl1 
(K and M) are both significantly decreased in the Hdac1/2ShhcreDKO mutant lungs 
at E17.5 (L and N). Goblet cell marker Clca3 is not altered in the mutant lungs (O 
and P). Scale bars: A and C=40µm; E, G and L=20µm. 
Eso=esophagus.  Scale bars: B, F, H, L, N and P=20µm; J and D=40µm, 
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Figure 2.6: Loss of Hdac1/2 results in a de-repression of Bmp4 expression 
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Figure 2.6: Loss of Hdac1/2 results in a de-repression of Bmp4 expression 
(A) qPCR analysis of major signaling pathway components in Hdac1/2ShhcreDKO 
mutants shows a significant increase in Bmp4 expression . 
(B) In situ hybridization shows increased and expanded Bmp4 expression 
throughout the entire dysmorphic lung endoderm of Hdac1/2ShhcreDKO mutants 
(arrows). 
Scar bar: B=20µm. 
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Figure 2.7: Exogenous Bmp4 can inhibit proximal fate while promoting 
distal fate during lung development 
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Figure 2.7: Exogenous Bmp4 can inhibit proximal fate while promoting 
distal fate during lung development 
(A-F) Treatment of lung explant cultures at E11.5 with recombinant Bmp4 
(rBmp4) for 48 hours suppresses Sox2 expression (arrowhead in C) and 
expands Sox9+ cells in lung endoderm (arrowheads in E). Note that Sox9 
normally marks the distal lung epithelial progenitor cells (arrows in D and E) as 
well as proximal mesenchyme (arrowhead in D). In rBmp4 treated explants, Sox9 
expression is expanded into the proximal airway epithelium of the lung explants 
(arrowheads in E). qPCR shows decreased Sox2 expression along with a 
decrease in other early proximal epithelial markers including Scgb3a2 and 
SSEA1 (Fut4) in rBmp4 treated explants (F). qPCR also shows increased 
expression of Id2 in rBmp4 treated lung explants (F). 
(G-J) c-Caspase 3 immunostaining shows that apoptosis is increased in the 
Hdac1/2ShhcreDKO mutant lungs (G). This increase in apoptosis is not spatially 
restricted to the proximal compartment as shown by sections through the anterior 
to the posterior regions of the lung (G and J). Treatment of lung explants with 
recombinant Bmp4 increases lung epithelial apoptosis level as shown by 
increased c-Caspase 3 staining compared to BSA-treated explants (I and J). 
Scale bars: G=10µm; E and I=20µm 
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Figure 2.8: Reducing Bmp4 can partially rescue the loss of Sox2+ 
progenitors caused by Hdac1/2 deletion 
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Figure 2.8: Reducing Bmp4 can partially rescue the loss of Sox2+ 
progenitors caused by Hdac1/2 
(A-F) Immunostaining for Sox2 in control, Hdac1/2ShhcreDKO mutant and 
Hdac1/2ShhcreDKO:Bmp4Δ/+ lungs shows that loss of one copy of Bmp4 partially 
rescues Sox2 expression in the Hdac1/2ShhcreDKO mutants (arrowheads in C and 
(G-J) Loss of one copy of Bmp4 reduces the epithelial apoptosis level in the 
Hdac1/2ShhcreDKO mutants. 
Scale bars: C and I=20µm; F=40µm. 
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Figure 2.9: Bmp4 is a direct target of Hdac1/2 during lung development 
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Figure 2.9: Bmp4 is a direct target of Hdac1/2 during lung development 
(A and B) ChIP assays using gel electrophoresis (A) and qPCR (B) show that 
Hdac1/2 bind to the Bmp4 promoter in the lung. 
(C-E) Lung epithelial cell line MLE12 were transfected with either Hdac1/2 siRNA 
or Control siRNA to knockdown Hdac1/2 in the cells (C). ChIP assays show 
increased H3K9 acetylation level at Bmp4 promoter after knocking down Hdac1/2 
(D), while an intergenic region upstream of Bmp4 is not affected (E). 
(F and G) TSA treated E11.5 lung explants also show increased level of H3K9 
acetylation at Bmp4 promoter (I-J). Loss of one copy of Bmp4 partially rescues 
Sox2 expression in the Hdac1/2ShhcreDKO mutants (K-P). 
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Figure 2.10: Endoderm progenitor proliferation is mediated in part by 
Hdac1/2 repression of Rb1 
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Figure 2.10: Endoderm progenitor proliferation is mediated in part by 
Hdac1/2 repression of Rb1 
(A and B) Phospho-histone H3 (PO4-H3) immunostaining shows that proliferation 
is decreased throughout Hdac1/2ShhcreDKO mutant lung endoderm.  
(C) Heatmap of genes associated with cell proliferation from Hdac1/2ShhcreDKO 
mutants shows increased expression of Rb1 and p21/Cdkn1a.  
(D-I) Immunostainings for Rb1, p16/Ink4a, and p21/Cdkn1a demonstrate that 
these cell cycle inhibitors are undetectable in control lungs at E12.5, but are 
induced in Hdac1/2ShhcreDKO mutants.  
(J) qPCR analysis confirms the de-repression of Rb1 and p21/Cdkn1a transcripts 
at E12.5.  
(K and L) ChIP assays using gel electrophoresis and qPCR show that Hdac1/2 
binds robustly on the Rb1 proximal promoter in the developing lungs.  
(M and N) Knocking down Hdac1/2 in MLE12 cells or treating lung explants with 
TSA increases the H3K9 acetylation level at the Rb1 promoter. 
Scale bar: A=20µm; D-I=10µm. 
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Figure 2.11: Hdac1/2 are not required for the homeostasis of lung airway 
epithelium 
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Figure 2.11: Hdac1/2 are not required for the homeostasis of lung airway 
epithelium 
(A-D) Hdac1 (A and B) and Hdac2 (C and D) expression are significantly reduced 
in the airway epithelium of Hdac1/2Scgb1a1creDKO mutants compared to Scgb1a1cre 
controls.  
(E-L) Loss of Hdac1/2 expression in Hdac1/2Scgb1a1creDKO mutants does not 
disrupt airway epithelial morphology by H+E staining (E and I). Loss of Hdac1/2 
expression in Hdac1/2Scgb1a1creDKO mutants does not disrupt expression of 
secretory cell markers Scgb1a1 (F and J) and Sox2 (G and K). Loss of Hdac1/2 
expression does not disrupt expression of the ciliated epithelial marker TubbIV (H 
and L).  
(M) qPCR shows only a minor loss of expression for the secretory marker genes 
Scgb1a1 and Scgb3a2 and no significant change in Sox2 expression in 
Hdac1/2Scgb1a1creDKO mutants.  
Scale bars=20µm. 
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Figure 2.12: Hdac1/2 are required for regeneration of lung airway 
epithelium after injury 
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Figure 2.12: Hdac1/2 are required for regeneration of lung airway 
epithelium after injury 
(A-D) Immunostaining for Scgb1a1 shows the severe loss in secretory epithelial 
cells four days post-injury in both Scgb1a1cre and Hdac1/2Scgb1a1creDKO mutants. 
(E and F) Ten days post-injury, Scgb1a1+/Sox2+ secretory cells in the airways of 
the lung have not regenerated in Hdac1/2Scgb1a1creDKO mutants, while Scgb1a1cre 
controls have regenerated normally (E). qPCR shows a dramatic loss in 
Scgb1a1, Sox2, and Scgb3a2 expression with a much smaller loss in TubbIV 
expression 10 days post-injury (F).  
(G and H) At one month post-injury, Hdac1/2Scgb1a1creDKO mutants continue to lack 
regeneration of Scgb1a1+/Sox2+ secretory epithelium (G). qPCR at one month 
post-injury confirms decreased Scgb1a1, Sox2, and Scgb3a2 expression while 
TubbIV expression is unchanged (H).  
(I and J) Goblet cells are not significantly altered in the Hdac1/2Scgb1a1creDKO 
mutants compared to controls during the course of regeneration as shown by the 
immunostaining of Muc5ac and qPCR for Agr2. 
Scale bars: B, D, E and I= 20µm; G=40µm 
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Figure 2.13: Hdac1/2 repress cell cycle inhibitors to allow airway 
regeneration after injury 
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Figure 2.13: Hdac1/2 repress cell cycle inhibitors to allow airway 
regeneration after injury 
(A) qPCR shows that Bmp4 expression level is not altered in the 
Hdac1/2Scgb1a1creDKO lungs compared to controls both when uninjured or ten days 
after injury with naphthalene. 
(B and C) Cell proliferation as measured by Ki67 immunostaining is reduced by 
more than 80% during the airway epithelial regeneration process from days 4-10 
in Hdac1/2Scgb1a1creDKO mutants. 
(D-I) Rb1, p21/Cdkn1a and p16/Ink4a expression levels are up-regulated during 
the process of airway regeneration. 
 
(J-O) Immunostaining shows that expression of Rb1, p21/Cdkn1a and p16/Ink4a 
is not increased in uninjured Hdac1/2Scgb1a1creDKO lungs.  
Scale bars: J=20µm. E, G and I=10µm. 
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Figure 2.14: Decreased HDAC1/2 expression and increased RB1 expression 
inhuman COPD samples 
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Figure 2.14: Decreased HDAC1/2 expression and increased RB1 expression 
in human COPD samples 
(A-D) Immunostainings for HDAC1/2 show that the expression levels of both 
proteins are decreased in the COPD lung epithelium.  
(E and F) Immmunostaining shows that RB1 is highly expressed in the COPD 
lung airway epithelium in comparison to normal lung samples. 
Scale bars=40µm. 
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Figure 2.15: A model diagram of how Hdac1/2 function during lung 
development and regeneration 
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Figure 2.15: A model diagram of how Hdac1/2 function during lung 
development and regeneration 
(A) A model for Hdac1/2 action during both lung development and postnatal 
airway epithelial regeneration. Hdac1/2 inhibits Bmp4, which in turn inhibits 
Sox2+ proximal lung progenitor and promotes Sox9+ distal progenitor 
development. Hdac1/2 also regulate Rb1 which inhibits endoderm proliferation 
during development and during lung regeneration. 
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Chapter 3: Regulation of lung sacculation and alveolar epithelial 
cell remodeling by HDAC3 
The majority of the data described in this chapter is part of a forthcoming 
manuscript. 
 
Introduction 
As reviewed in Chapter 1, the terminal stages of lung development, called lung 
sacculation and alveologenesis, involve both differentiation of distal lung 
endoderm progenitors and extensive cellular remodeling of the resultant 
epithelial lineages. These processes are coupled with dramatic expansion of 
distal airspace and surface area, along with the close juxtaposition of the luminal 
epithelium with the pulmonary vasculature. Despite the importance of these late 
developmental processes and their relation to neonatal respiratory diseases, little 
is understood about the molecular and cellular pathways critical for their 
successful completion.  
 
Recent evidence has begun to shed light on the role of histone deacetylases 
(HDACs) during lung endoderm progenitor specification (63). As shown in 
Chapter 2, two members of class I HDACs, Hdac1 and 2, are required for 
development of early Sox2+ proximal lung endoderm progenitors, through 
regulation of Bmp4 and cell cycle regulators including Rb1 (63). However, what 
roles other class I HDACs including Hdac3 play in lung development and 
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homeostasis has remained unclear. Importantly, Hdac3 associates with the 
NCoR/SMRT complex whereas Hdac1/2 associate with complexes such as 
NuRD/Sin3a (44-47), suggesting potentially different roles for these HDACs and 
chromatin remodeling complexes during lung development.  
 
In this chapter, we show that a histone deacetylase 3 (Hdac3) mediated 
epigenetic pathway is critical for the proper remodeling and expansion of the 
distal lung saccules into primitive alveoli. Loss of Hdac3 in the developing lung 
epithelium leads to a reduction of alveolar type 1 cell spreading and a disruption 
of lung sacculation. Hdac3 represses miR-17-92 expression, a miRNA cluster 
that regulates Tgf-β signaling. De-repression of miR-17-92 in Hdac3 deficient 
lung epithelium results in decreased Tgf-β signaling activity. Importantly, 
inhibition of Tgf-β signaling and over-expression of miR-17-92 can mimic the 
defects observed in Hdac3 null lungs. Importantly, loss of miR-17-92 expression 
rescues many aspects of the defects caused by loss of Hdac3 in the lung. These 
studies reveal an intricate epigenetic pathway where Hdac3 is required to 
repress miR-17-92 expression to allow for proper Tgf-β signaling during lung 
sacculation. This pathway is essential for epithelial cell spreading and remodeling 
of the lung alveolar airspace in preparation for gas exchange in the lung. 
 
Results 
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Loss of Hdac3 in the lung epithelium leads to defects in sacculation 
Lung sacculation and alveologenesis results in the extensive dilation and 
expansion of the distal lung region after initial specification and differentiation of 
AT1 and AT2 cells (refer to Chapter 1 Figure 1.2). Examination of Hdac3 
expression during lung development showed that it is broadly expressed in both 
epithelial and mesenchymal lineages (Figures 3.1A and 3.1C). Given the 
importance of Hdac1 and 2 in early lung development (63), we sought to 
determine whether Hdac3 is also essential for lung development through genetic 
inactivation of Hdac3 using the Shhcre line that drives cre-dependent 
recombination in the lung endoderm starting at E8.75 (64, 93). Hdac3 was 
efficiently deleted in the developing lung epithelium of Shhcre:Hdac3f/f mutants as 
shown by immunostaining (Figures 3.1B and 3.1D). Approximately two-thirds of 
the newborn Shhcre:Hdac3f/f mutant pups died postnatal day 2 (P2) and the rest 
died by P10.  
 
Shhcre:Hdac3f/f mutants developed normally and showed no obvious lung defects 
up to E17.5, a time point that marks early sacculation (Figures 3.1E-3.1H). 
However, histological analysis of E18.5 Shhcre:Hdac3f/f mutant lungs revealed 
significantly compacted distal airspaces and increased thickness of the alveolar 
wall (Figures 3.1I-3.1L). These defects were further illustrated by whole mount 
staining of the AT1 cell marker Aqp5 and subsequent 3D reconstruction of the 
saccular surfaces, which showed a compressed distal lung region with little 
airspace dilation in the Shhcre:Hdac3f/f mutants (Figures 3.1M and 3.1N).  
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Hdac3 does not regulate lung sacculation through modulating cell 
proliferation or survival 
Previous studies have shown that one common function of Hdac proteins is to 
regulate cell proliferation and survival through direct de-repression of cell cycle 
inhibitors (48-50). BrdU labeling or phospho-histone H3 immunostaining did not 
reveal any detectable changes in cell proliferation at E16.5 and E18.5 (Figures 
3.2A-3.21F). Moreover, there were no obvious changes in cell apoptosis as 
noted by cleaved-caspase 3 immunostaining at these time points (Figures 3.2G-
3.2J). These data suggest that Hdac3 does not control lung sacculation through 
modulation of cell proliferation or survival.  
 
Hdac3 is dispensable for epithelial lineage differentiation during lung 
sacculation 
AT1 and AT2 cells are the major epithelial cell lineages lining the alveolar sacs 
and are thought to derive from a common precursor (17, 22). Their differentiation 
and maturation from the Sox9+ distal progenitor pool is an important process 
occurring at sacculation, and decreased AT1 cell differentiation in particular is 
associated with sacculation and alveolarization defects during lung development 
(30, 94, 95). To assess if the alveolar epithelial cell fate commitment occurs 
properly in the Shhcre:Hdac3f/f mutants, we examined the expression of several 
markers for AT2 and AT1 cells. AT2 cells appeared to differentiate normally in 
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Shhcre:Hdac3f/f lungs, as the expression levels of Sftpc, Sftpb, and Abca3 were 
not significantly altered (Figures 3.3A-3.3C and 3.4A-3.4F). AT1 cell marker 
Aqp5 was unchanged as shown by immunostaining and qPCR (Figures 3.3A and 
3.4A-3.4F). Expression of Pdpn, which is present in both AT1 cells and lymphatic 
endothelial cells, was modestly reduced by qPCR but was unaltered using 
immunostaining (Figures 3.3A, 3.3D and 3.3E). In addition, expression of 
markers for proximal airway epithelial lineages and lung mesenchymal lineages 
were not significantly altered in the Shhcre:Hdac3f/f mutant lungs (Figures 3.3F-
3.3M). These data suggest that the lineage commitment of multiple cell types, 
including that of AT1 and AT2 cells, is largely unaffected by loss of Hdac3. This 
is in contrast to a previous mouse model in which a mutation of SMRT that 
abrogated its interaction with nuclear receptors resulted in inhibition of AT1 cell 
differentiation via regulation of transcription factor Klf2. However, Klf2 expression 
in our Shhcre:Hdac3f/f lungs was not altered (Figure 3.3N), suggesting that Hdac3 
and SMRT may have non-overlapping roles in lung development.  
 
Hdac3 is required for proper spreading of AT1 cells during lung sacculation 
After their appearance at E17.5 as noted by Aqp5 expression, AT1 cells 
gradually spread and cover 95% of the alveolar surface to form the thin gas-
diffusible interface between the airspace and pulmonary vasculature. This 
morphological change started to occur rapidly after AT1 cell commitment at 
E17.5, and the flattened morphology of AT1 cells was evident in the E18.5 wild-
type lungs (Figure 3.4A-3.4C). In contrast, the majority of Shhcre:Hdac3f/f mutant 
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AT1 cells appeared densely packed and failed to acquire a flat squamous cell 
shape at this stage (Figure 3.4F). Using ImageJ to quantitate the luminal 
distance between neighboring AT1 cells, we found that this distance was greatly 
reduced in the Shhcre:Hdac3f/f mutant lungs (Figure 3.4G-3.4H). To further 
examine whether this disruption of AT1 cell morphology was due to a cell intrinsic 
defect in spreading or merely an indirect consequence of unexpanded distal 
airways, we isolated and cultured E18.5 control and Shhcre:Hdac3f/f mutant lung 
primary epithelial cells and examined their ability to spread in vitro. 
Immunostaining for Pdpn showed that AT1 cells from Shhcre:Hdac3f/f mutant 
lungs were unable to spread as extensively as those from their control littermate 
lungs (Figures 3.4I-3.4M). These data indicate that while epithelial Hdac3 is 
dispensable for alveolar AT1 and AT2 cell lineage commitment, it is essential for 
promoting AT1 cell spreading during lung sacculation. 
 
miR-17-92 and the miRNAs in the Dlk1-Dio3 locus are de-repressed upon 
loss of Hdac3 expression in the lung epithelium 
To further define the molecular changes that occur upon loss of Hdac3 
expression in the lung epithelium, we examined the changes in the transcriptome 
of Shhcre:Hdac3f/f mutant lungs at E18.5. 1070 genes were differentially 
expressed upon loss of Hdac3 expression, with 569 genes up-regulated and 501 
genes down-regulated. Strikingly, expression of 62 microRNA (miRNA) primary 
transcripts were increased in the Shhcre:Hdac3f/f mutant lungs (Figure 3.5A). 
Analysis of these miRNAs revealed that the majority of them belonged to two 
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genetic loci: the large imprinted Dlk1-Dio3 locus located on chromosome 12 and 
the miR-17-92 cluster located on chromosome 14. To determine whether these 
miRNAs were de-repressed in a cell autonomous manner by loss of Hdac3, we 
performed mature miRNA qPCR on the isolated EpCAM+ epithelial cells and 
EpCAM- mesenchymal cells from E18.5 lungs (Figure 3.5B and 3.5C). These 
experiments confirmed that these two miRNA loci were de-repressed in lung 
epithelial cells but not in mesenchymal cells after an epithelial cell-specific loss of 
Hdac3 (Figure 3.5D and 3.5E). Notably, most of the miR-17-92 family members 
were significantly up-regulated in the Hdac3-deficient lung epithelium, whereas 
fewer of the miRNAs in the Dlk1-Dio3 locus were de-repressed (Figure 3.5D).  
 
Loss of Hdac3 causes similar transcriptome changes to miR-17-92 
overexpression 
Previous studies have reported that miR-17-92 is highly expressed at early 
stages of lung development but declines as development proceeds (26, 96). 
Transgenic over-expression of miR-17-92 in the developing lung epithelium using 
the mouse Sftpc promoter (Sftpc::MIR17-92) inhibited epithelial differentiation 
and resulted in immature sacculation similar to but more severe than the 
Shhcre:Hdac3f/f mutant lungs (26). This suggests that Hdac3 may play a role in 
repressing the expression of miR-17-92 to allow proper lung sacculation to 
proceed. To determine whether the transcriptome changes caused by loss of 
Hdac3 were similar to those caused by over-expression of miR-17-92, we 
compared the differentially up-regulated and down-regulated genes from the 
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previously reported Sftpc::MIR17-92 microarray (26), to the transcriptome 
analysis we performed on the Shhcre:Hdac3f/f mutant lungs. Using gene set 
enrichment analysis (GSEA), we found that the up-regulated gene set from the 
Sftpc::MIR17-92 microarray were enriched in the genes up-regulated in the 
Shhcre:Hdac3f/f transcriptome data (Figure 3.6A). Conversely, the down-regulated 
gene set from the Sftpc::MIR17-92 microarray were enriched in the genes down-
regulated in the Shhcre:Hdac3f/f transcriptome data (Figure 3.6B). These data 
demonstrate that loss of Hdac3 in the developing lung epithelium results in gene 
expression changes similar to that caused by over-expression of miR-17-92, 
suggesting that de-repressed miR-17-92 expression may underlie some aspects 
of the phenotype in Shhcre:Hdac3f/f mutants.  
 
miR-17-92 and the miRNAs in the Dlk1-Dio3 locus suppress Tgf-β signaling  
Since both the miR-17-92 and Dlk1-Dio3 locus miRNAs were de-repressed upon 
loss of Hdac3 in the developing lung epithelium, we compared the predicted 
target gene lists of these two miRNA clusters to identify common down-stream 
molecular pathways. A total of 305 common target genes were differentially 
expressed in the Shhcre:Hdac3f/f mutant lungs and Signaling Pathway Impact 
Analysis (SPIA) on those genes revealed Tgf-β signaling and ECM-receptor 
interaction as top candidate pathways targeted by these two miRNA clusters 
(Figure 3.7A). Consistent with our analysis, previous studies have shown that 
miR-17-92 cluster is a potent inhibitor of Tgf-β signaling through targeting key 
components of the Tgf-β pathway as well as Tgf-β target genes (97, 98). To 
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verify that these Tgf-β signaling components and cell-ECM genes were down-
regulated in the Shhcre:Hdac3f/f mutant lungs, qPCR analysis was performed 
which revealed that most of these genes were significantly down-regulated in the 
lung epithelium but not mesenchyme of Shhcre:Hdac3f/f mutants (Figure 3.7B, 
3.7C and data not shown). To determine whether the changes in Tgf-β signaling 
components caused a decrease in Tgf-β signaling activity, immunostaining for p-
Smad2 was performed at E18.5. p-Smad2 level was significantly decreased in 
the distal epithelium and mesenchyme as noted by co-staining for the lung 
epithelial marker Nkx2.1, consistent with a decrease in Tgf-β signaling 
components including Tgf-β ligands (Figure 3.7D-3.7I). However, the p-Smad2 
level in the proximal airway epithelium of Shhcre:Hdac3f/f mutants was relatively 
unaffected (Figure 3.7D-3.7I, dotted outline).  
 
Inhibition of Tgf-β signaling results in defects in lung sacculation and AT1 
cell spreading 
Tgf-β signaling is widely recognized as a crucial player in cell spreading, 
adhesion and tissue morphogenesis (99-102). Global loss of either 
Tgfβ2 or Tgfβ3 led to perinatal lung defects (23, 24). Tgfβ3 null lungs, in 
particular, were characterized by alveolar hypoplasia and mesenchymal 
thickening that is reminiscent of Shhcre:Hdac3f/f mutant lungs (23). Moreover, lung 
epithelial-specific loss of TgfβRI (ALK5) also led to collapsed distal airways 
before birth, although detailed defects in the distal epithelial development were 
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not explored in this study (25). To further investigate if decreased Tgf-β signaling 
could lead to improper remodeling of AT1 cells including reduced cell spreading, 
we cultured E16.5 wild type lung explants at the air-liquid interface in the 
absence or presence of the TgfβRI inhibitor SB431542. The development of wild 
type lung explants partially mimicked lung sacculation in vivo, as evidenced by 
an expansion of distal airways and the specification and early differentiation of 
AT1 cells, which is noted by Aqp5 expression and their flattened appearance 
(Figures 3.8A and 3.8D). Treatment with SB431542 resulted in greatly narrowed 
distal airway lumen and disrupted the morphology and remodeling of AT1 cells, 
including reduced spreading that resembled Shhcre:Hdac3f/f mutant lung explants 
cultured in parallel (Figures 3.8A-3.8I). Moreover, treatment of wild-type lung 
epithelial cell culture with SB431542 also reduced the spreading of AT1 cells in 
vitro (Figures 4J-4M). Together, these data suggest that epithelial-specific loss of 
Hdac3 in the lung suppresses Tgf-β signaling and genes related to cell-ECM 
interaction, through up-regulation of the miR-17-92 and the Dlk1-Dio3 miRNA 
loci. Moreover, these data demonstrate that loss of Tgf-β signaling can lead to 
reduced AT1 cell spreading and defective lung sacculation.  
 
Over-expression of miR-17-92 can phenocopy the loss of Hdac3 and lead to 
defective AT1 cell spreading and lung sacculation 
A previous study showed that transgenic over-expression of miR-17-92 led to a 
block in lung epithelial differentiation with an increase in Sox9+ progenitors (26). 
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However, our Shhcre:Hdac3f/f mutant lungs did not display a change in Sox9 
expression or alveolar epithelial differentiation (Figures 3.9A-3.9D). Such 
differences in the overall phenotype observed between these two models could 
be due to the differing levels of increased miR-17-92 expression, given that the 
level of miR-17-92 up-regulation in Shhcre:Hdac3f/f mutant lungs was more 
modest than when using the powerful mouse Sftpc promoter (Figure 3.5D and 
(26)). Since our data suggest significant molecular similarities between miR-17-
92 over-expression and loss of Hdac3 expression during lung epithelial 
development, we over-expressed miR-17-92 by utilizing the Shhcre line and a 
Rosa26-MIR17-92 knock-in allele (R26MIR-17-92) that has been previously 
described to deliver a moderate level of miR-17-92 expression upon cre 
recombination (103). We confirmed that the epithelial miR-17-92 expression level 
in these Shhcre:R26MIR-17-92  mutants was up-regulated by approximately 2-4 fold, 
which was similar to that in Shhcre:Hdac3f/f mutant lungs (Figure 3.9E). 
Histological analysis showed that E18.5 Shhcre:R26MIR17-92  mutant lungs exhibited 
a decrease in the distal airway luminal size and an increase in the alveolar wall 
thickness, similar to but less severe than the Shhcre:Hdac3f/f mutant lungs 
(Figures 3.10A-3.10H). Aqp5 staining revealed that a large proportion of AT1 
cells in Shhcre:R26MIR17-92  lungs were densely packed and had not spread 
properly (Figures 3.10I-3.10K). Multiple components of the Tgf-β signaling 
pathway, along with genes related to cell-ECM interaction, were decreased in 
Shhcre:R26MIR17-92 lung epithelial cells (Figures 3.10L and 3.10M), as well as in 
the MLE12 mouse lung epithelial cells over-expressing miR-17-92 (Figure 3.9F). 
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These data suggest that elevated levels of this miRNA cluster can directly 
suppress Tgf-β signaling in lung epithelial cells. Similar to the Shhcre:Hdac3f/f 
lungs, we did not observe an increase in Sox9+ or Sox2+ epithelial progenitor 
cells in the Shhcre:R26MIR-17-92  lungs at E18.5 (Figures 3.9A-3.9D and 3.9G-3.9L), 
suggesting that a higher expression level of miR-17-92 may be required to trigger 
such a block in distal epithelial differentiation. The phenotype observed in 
Shhcre:R26MIR17-92  lungs including the extent of Tgf-β signaling down-regulation 
was generally milder than in Shhcre:Hdac3f/f lungs, suggesting that additional 
mechanisms, such as the up-regulation of Dlk1-Dio3 miRNAs, might also play a 
role. 
 
Lung sacculation requires Hdac3 mediated repression of miR-17-92 
To determine if the sacculation defects in Shhcre:Hdac3f/f lungs are directly 
mediated by increased expression of miR-17-92, we generated mice lacking both 
Hdac3 and miR-17-92 expression (Shhcre:Hdac3f/f:MIR17-92f/f). In contrast to a 
previous report of a lung hypoplasia phenotype in the miR-17-92 global knockout 
mice (104), Shhcre:MIR17-92f/f mutants were viable with no obvious lung 
phenotype (data not shown). Next, we generated Shhcre:Hdac3f/f:MIR17-92f/f 
mutants and compared these to Shhcre:Hdac3f/f mutants at E18.5. The 
sacculation defects observed in Shhcre:Hdac3f/f mutant lungs, including thickened 
alveolar wall and compacted distal saccular lumen, were significantly alleviated in 
Shhcre:Hdac3f/f:MIR17-92f/f mutant lungs (Figures 3.11A-3.11J). AT1 cells in 
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Shhcre:Hdac3f/f:MIR17-92f/f mutant lungs also exhibited greater spreading with a 
more flattened appearance compared to those in the Shhcre:Hdac3f/f mutant lungs 
(Figures 3.11K-3.11N). Together, these studies revealed that loss of miR-17-92 
significantly restores the AT1 cell remodeling and sacculation defects in 
Shhcre:Hdac3f/f lungs. 
 
To test whether loss of miR-17-92 expression would normalize Tgf-β signaling as 
well as the gene expression changes observed in Shhcre:Hdac3f/f mutants, we 
isolated EpCAM+ cells from Shhcre:Hdac3f/f:MIR17-92f/f mutant lungs and 
performed qPCR analysis. Most of the gene expression changes were 
completely or partially normalized in Shhcre:Hdac3f/f:MIR17-92f/f mutant lungs 
compared to Shhcre:Hdac3f/f mutant lungs (Figures 3.12A and 3.12B). Moreover, 
loss of miR-17-92 expression also increased p-Smad2 level in the distal alveolar 
region of Shhcre:Hdac3f/f:MIR17-92f/f mutant lungs (Figures 3.12C-3.12K). These 
data suggest that miR-17-92, through targeting the Tgf-β pathway, is a critical 
modulator of Hdac3 mediated regulation of lung sacculation and the remodeling 
of the alveolus required for postnatal lung function (Figure 3.12L). 
 
Effects of Hdac3 on adult lung injury model 
Previous studies have suggested that activation of Tgf-β signaling is involved in 
promoting the pathogenesis of several crucial lung diseases including pulmonary 
fibrosis (105). In mice, inhibiting the Tgf-β pathway has been shown to alleviate 
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fibrosis triggered by bleomycin (106). Given that loss of Hdac3 can reduce Tgf-β 
signaling during lung development, we asked if loss of Hdac3 in the adult lung 
epithelium would blunt the fibrotic responses induced by bleomycin. We 
generated eight-week old SftpcCreER;Hdac3f/f mice and induced the deletion of 
Hdac3 in the AT2 cells by three times of tamoxifen injection. We found no gross 
lung phenotype in the SftpcCreER;Hdac3f/f lungs after tamoxifen induction (data not 
shown). To assess whether these lungs would respond differently to injury, we 
treat the mice with bleomycin with intratracheal administration. We found that 3 
weeks after bleomycin injury, the area of fibrotic loci in the SftpcCreER;Hdac3f/f 
mutant lungs appear to be significantly smaller than control lungs (Figures 3.13A-
3.13F), suggesting that loss of Hdac3 may alleviate the fibrotic responses 
induced by bleomycin. The effect of Tgf-β pathway is generally thought to be pro-
fibrotic. However, it is obscure whether Tgf-β pathway has any roles in regulating 
alveolar epithelial regeneration and remodeling during fibrosis, aside from 
promoting the myofibroblast proliferation and collagen deposition.  Interestingly, 
Aqp5 staining showed that the AT1 cells were less spread in the 
SftpcCreER;Hdac3f/f mutant lungs after injury, consistent with the developmental 
data (Figures 3.13G-3.13I). Future studies needs to be done to determine 
whether miR-17-92 and Tgf-β are altered in the SftpcCreER;Hdac3f/f mutant lungs.  
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Discussion 
Lung sacculation and alveologenesis remain poorly-understood developmental 
processes that comprise elegant and complicated events of cellular 
differentiation and remodeling. Defects in these developmental processes can 
lead to serious lung diseases in the newborn including bronchopulmonary 
dysplasia. How alveolar epithelial cells differentiate and remodel to form the 
intricate gas exchange interface required for postnatal respiration is poorly 
understood. In particular, how AT1 cells acquire their unique morphology during 
late lung development that allows them to cover 95% of alveolar luminal surface 
and facilitate the rapid diffusion of oxygen to the pulmonary vascular plexus is 
unknown. Our study demonstrates that an epigenetic pathway directed by Hdac3 
regulates alveolar epithelial cell remodeling and saccular development in the 
mouse lung. Hdac3 is essential for AT1 cells to spread and acquire a sheet-like 
morphology during sacculation. Hdac3 accomplishes this developmental role 
through repression of the miR-17-92 and the Dlk1-Dio3 miRNA clusters, which in 
turn, allows for appropriate levels of Tgf-β signaling.  
 
Hdac3 is a class I HDAC that interacts with the co-repressive complexes NCoR 
and SMRT (44-46). A previous study reported that a SMRT knock-in allele that 
abrogated its interaction with nuclear receptors produced defects in lung 
sacculation and inhibited AT1 cell differentiation (62). This phenotype was 
partially attributed to the downstream target Klf2 and its role in promoting the AT1 
cell differentiation program. In contrast to these results, loss of Hdac3 does not 
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significantly perturb the specification of the AT1 cell lineage and Klf2 expression 
levels appeared to be unchanged. One possibility for this discrepancy could be 
that our model examined the epithelial cell-specific function of Hdac3 while the 
SMRT knock-in mutation is a globally expressed point mutation. Moreover, the 
SMRT knock-in mutation only abrogated its interaction with nuclear receptors 
while still bound to Hdac3. Recent studies have also implicated that SMRT has 
Hdac3-independent functions in some contexts (107), and that SMRT and NCoR 
have non-redundant in vivo functions (42, 108), suggesting that despite the co-
existence of Hdac3 and SMRT in the same complex, these two proteins are not 
completely interchangeable in their molecular functions.  
 
Previous studies have shown that the miR-17-92 cluster is highly expressed in 
the early stages of lung development and declines as development proceeds (26, 
96). The down-regulation of this cluster is important for late lung development as 
transgenic epithelial specific over-expression of miR-17-92 impeded 
differentiation and saccular development (26). Our study demonstrates that 
Hdac3 plays a regulatory role in repressing this cluster of miRNAs in the lung 
epithelium and that elevated levels of miR-17-92 disrupt formation of distal 
saccules and primitive alveoli by inhibiting AT1 cell spreading. miR-17-92 can 
directly target and inhibit multiple components of Tgf-β signaling including Tgf-β 
responsive genes (97, 98). Consistent with this observation, we found a down-
regulation of genes involved in Tgf-β signaling specifically in the Hdac3 deficient 
lung epithelium that can be partially restored by epithelial specific loss of miR-17-
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92. Tgf-β signaling is known as a critical regulator of cell spreading, adhesion 
and migration. Previous studies have suggested that it plays a role in lung 
sacculation and alveologenesis but it has remained unclear what cellular and 
molecular processes it regulates during this stage of development (23-25). We 
found that Tgf-β signaling promotes the spreading of AT1 cells during lung 
sacculation, supporting a model in which the morphogenetic changes of AT1 
cells are directed by an Hdac3-miRNA-Tgf-β molecular cascade. This process of 
AT1 cell spreading is likely to be important for the rapid expansion of distal 
saccular surface area that occurs during late lung development in preparation for 
alveologenesis. We also observed increased expression of miRNAs in the 
maternally imprinted Dlk1-Dio3 locus, which is regulated by histone acetylation in 
induced pluripotent stem cells (109). Several miRNAs in this locus including 
miR376c are reported or predicted to directly target components of the Tgf-β 
pathway (110, 111), suggesting that this cluster of miRNAs also plays an 
important role in repressing Tgf-β signaling.  
 
The generation of the thin gas-diffusible interface between the external 
environment and the vasculature remains a unique characteristic of the 
mammalian respiratory system. Our data suggest that Hdac3 plays a critical role 
in the initial establishment of alveolar structure through promoting AT1 cell 
spreading by inhibiting miR-17-92 mediated repression of Tgf-β signaling. Our 
preliminary data on the adult bleomycin injury also suggest that the Hdac3/miR-
17-92/Tgf-β molecular pathway might also play a role in the adult lung epithelial 
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regeneration and remodeling. Such information may be beneficial to our 
understanding of how neonatal respiratory diseases occur and how an alveolus 
re-establishes its structure after postnatal injury.  
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Methods and Materials 
Animals 
The generation and genotyping of Hdac3 flox, Shhcre, R26MIR17-92 and MIR17-92 flox 
alleles have been previously described (64, 93, 103, 104). All animal work was 
performed in accordance to the guidance of the University of Pennsylvania 
Institutional Animal Care and Use Committee. 
 
Quantitative PCR 
For mRNA qPCR, total RNA was isolated from lungs or cells at indicated time 
points by RNeasy Mini Kit (Qiagen) or RNeasy Micro Kit (Qiagen). First strand 
cDNA synthesis was performed using SuperScript III Reverse Transcriptase (Life 
Technologies). Quantitative PCR was performed by using the SYBR green 
system (Applied Biosystems) with primers listed in Table 3.1. Gapdh expression 
level was used as an internal control. For mature miRNA qPCR, MirVana miRNA 
Isolation Kit (Life Technologies) was used to isolate total RNA that contains small 
RNAs. The TaqMan MicroRNA Assays (Life Technologies) was used to 
quantitate various miRNA levels. Sno202 was used as an internal control for 
miRNA quantity. 
 
Histology 
Tissues were fixed in 4% paraformaldehyde overnight and subject to paraffin 
sectioning. Immunohistochemistry was performed by using the following 
antibodies and concentrations: Hdac3 (Santa Cruz, 1:10), Nkx2.1 (Santa Cruz, 
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1:50), p-Smad2 (Millipore, 1:1000), Sox2 (Seven Hills, 1:500), Sox9 (Santa Cruz, 
1:100), Sftpc (Santa Cruz, 1:50), Sftpb (Chemicon, 1:100), Aqp5 (Abcam, 1:100), 
Pdpn (Hybridoma Bank, 1:50), Scgb1a1 (Santa Cruz, 1:20), TubbIV (BioGenex, 
1:20), Pdgfrα (Cell Signaling 1:25), Pecam (Pharmingen, 1:500), c-Caspase 3 
(Cell Signaling, 1:50), BrDU (Abcam, 1:100) and phospho-histone H3 (Cell 
Signaling, 1:200). Whole mount staining was performed as previously described 
(6). 
 
Quantification of Alveolar Wall thickness and Airway Lumen Area  
For each sample, three pictures were taken under 40x objective lens. The 
method for quantification of alveolar wall thickness was previously described 
(112). The areas for distal airways was measured by using the measurement 
function in ImageJ and calculated for mean value and standard deviation.  
 
Transcriptome and bioinformatic analysis 
RNA was isolated from E18.5 lungs from Shhcre control and Shhcre:Hdac3f/f 
mutant embryos. Five lungs were collected for either control or Shhcre:Hdac3f/f 
group. The RNA was then used to generate a biotinylated cRNA probe library for 
Affymatrix Mouse Gene 2.0ST array. Microarray data were analyzed using the 
Oligo package available at the Bioconductor website (www.bioconductor.org). 
The raw data were background-corrected by the Robust Multichip Average 
(RMA) method and then normalized by an invariant set method. Differential gene 
expression between the control and mutant mice was analyzed by the Limma 
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package available at the Bioconductor website. P-values obtained from the 
multiple comparison tests were corrected by false discovery rates. Heatmap 
displays were created using the heatmap.2 function in the R package gplots. The 
Gene Expression Omnibus accession number for the microarray data is 
GSE70684. 
 
Functional enrichment analysis of pathways and Gene Ontology terms was 
performed using the Gene Set Enrichment Analysis (GSEA) software package 
(PMID:16199517).  
For the functional analysis of genes altered by miR-17-92 overexpression, 
custom “gene sets’ of up- and down-regulated genes were created from a 
previous microarray study on the E18.5 miR-17-92-overexpressing lungs (26). 
Functional enrichment of miR-17-92 altered gene sets in the Hdac3 mutant 
transcriptome was formally tested using the Gene Set Enrichment Analysis 
(GSEA) software package (PMID: 16199517). Predicted miRNA-gene targets 
were obtained from microRNA.org website and only target predictions that were 
conserved and annotated with a “Good” mirSVR score were considered for 
analysis. Pathway analysis of genes targeted by miR-17-92 cluster and Dlk-Dio3 
locus was performed using the Signaling Pathway Impact Analysis (SPIA) R 
package (PMID: 18990722) using the KEGG pathway annotations.  
 
Lung Explant Culture 
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Lung explant culture was performed as previously reported (113). Briefly, E16.5 
lungs were dissected and diced into 0.5-1mm thick pieces and cultured on an air-
liquid interface with DMEM media for 48hrs. The explants were treated with 
10µM SB431542 or vehicle. 
 
Lung Epithelial Cell Isolation and Culture 
E18.5 lungs were dissected and digested by collagenase and dispase to obtain 
single cell solution. Dynabeads Flow Comp Flexi Kit (Life Technologies) and 
EpCAM antibody (eBioscience) were used to isolate primary lung epithelial cells. 
The epithelial cells were cultured on the surface coated by fibronectin for eight 
days to achieve a well-spread epithelial sheet (114). The epithelial cells were 
treated with 10µM SB431542 from the first day of culture. Before 
immunostaining, cells were fixed in 4% PFA for 10min and permeabilized with 
0.1% Tween-20.  
 
Lentivirus 
Mouse MIR17-92 overexpression construct (26) were cloned into pLenti 7.3/V5-
DEST through the gateway cloning system. Lentivirus containing empty vector or 
MIR17-92 overexpression construct was packaged and produced as previously 
reported (112). MLE12 Cells were infected with lentivirus and allowed to grow for 
48hrs before RNA was extracted for qPCR. 
 
Bleomycin Injury 
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The SftpcCreER;Hdac3f/f mutant and control lungs were injected with 200mg/kg 
tamoxifen for three times at eight week old. Two weeks after tamoxifen induction, 
the mice were administered with 3 units/kg of bleomycin intratracheally. Lungs 
were collected 3 weeks after bleomycin administration. 
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Table 3.1: qPCR Primer Sequences 
Genes	   Forward	   Reverse	  
Gapdh	   AAATGGTGAAGGTCGGTGTGAACG	   ATCTCCACTTTGCCACTGC	  
Scgb1a1	   ATACCCTCCCACAAGAGACCAGGATA	   ACACAGGGCAGTGACAAGGCTTTA	  
Foxj1	   AGTGGATCACGGACAACTTCTGCT	   TTCTCCCGAGGCACTTTGATGAAG	  
TubbIV	   AACCCGGCACCATGGACTCTGT	   TGCCTGCTCCGGATTGACCAAATA	  
Aqp5	   ATGAACCCAGCCCGATCTTT	   ACGATCGGTCCTACCCAGAAG	  
Pdpn	   AGGTACAGGAGACGGCATGGT	   CCAGAGGTGCCTTGCCAGTA	  
Sftpc	   ACCCTGTGTGGAGAGCTACCA	   TTTGCGGAGGGTCTTTCCT	  
Sftpb	   TAGCCCTCTGCAGTGCTTCCAAA	   AGCTGGGACATACAGACTGACACA	  
Abca3	   TTCATCACCTGATGGCGGTGAAC	   ACGCATGATGGCTTTGTCTACAGC	  
Tbx4	   AAGGTGGGGCTGCATGAGAAGGA	   GAACATCCTCCTGCCGGCCTT	  
Vimentin	   TGACCTTGAACGGAAAGTGG	   GGACATGCTGTTCCTGAATCT	  
E-­‐Cadherin	   CCGTCCTGCCAATCCTGATGA	   ACTGCCCTCGTAATCGAACACCAA	  
Tgfb1	   CTGAACCAAGGAGACGGAATAC	   GGGCTGATCCCGTTGATTT	  
Tgfb2	   GTACCTTCGTGCCGTCTAATAA	   GTGCCATCAATACCTGCAAATC	  
Tgfb3	   CGCTACATAGGTGGCAAGAA	   CAAGTTGGACTCTCTCCTCAAC	  
Tgfbr1	   GTTCCGAGAGGCAGAGATTTAT	   CGTCCATGTCCCATTGTCTT	  
Tgfbr2	   GCTTCTCCCAAGTGTGTCAT	   GACTGCTGGTGGTGTATTCTT	  
Tgfbr3	   CTGGTGTGGCATGTGAAGA	   TCCTCTGTTTCTGCTGTCAAG	  
Smad2	   GATGACTACACCCACTCCATTC	   ATATCCAGGTGGTGGTGTTTC	  
Smad3	   CCTGAGTGAAGATGGAGAAACC	   CTGGCTGTAGGTCCAAGTTATT	  
Smad4	   GCAGAGTAATGCTCCAAGTATGT	   CGAATGTCCTTCAGTGGGTAAG	  
Col1a1	   TGACCGATGGATTCCCGTTC	   GCAGTGATAGGTGATGTTCTGG	  
Col1a2	   GATGTTGAACTTGTTGCTGAGG	   CAATGATTGTCTTGCCCCATTC	  
Col4a3	   CTCTCGAACCCTATATTAGCAGATG	   ACGGAGGGATAGCAGTAGTT	  
Col4a4	   CCCTGGATCAGATGTGATATACT	   CTCCTTTGGCTCCTCTTCTT	  
Itga7	   GGATTCCGAGGTGCGATTT	   ACATCCAGATTGAAGGCGATAG	  
Itgb1	   CTCCGGCCAGAAGACATTAC	   GGGTAATCTTCAGCCCTCTTG	  
Nidogen	  1	   GCACTCCTATGTGGTGATGAA	   ATCCGATGATGCCTCCAATG	  
Nidogen	  2	   CACCGAGGACAGTTTCCATTAC	   TCAATTCTGCTGTGGCCTTC	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Figure 3.1: Loss of Hdac3 in the lung epithelium leads to defects in 
sacculation 
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Figure 3.1: Loss of Hdac3 in the lung epithelium leads to defects in 
sacculation 
(A-D) Hdac3 is highly expressed in lung epithelium and mesenchyme at both 
E16.5 and E18.5 (A and C). Hdac3 is efficiently deleted in the epithelial cells of 
Shhcre:Hdac3f/f mutant lungs (arrows). White dotted lines outline the airway 
epithelium. 
(B-L) The Shhcre:Hdac3f/f mutants show no obvious defects in lung development 
at E16.5 or E17.5 by H&E staining (E-H). Green dotted lines outline the distal 
airways that have not undergone sacculation. At E18.5, the Shhcre:Hdac3f/f 
mutant lungs display disrupted lung sacculation (I and J) as evidenced by an 
increase in the alveolar wall thickness (K) and smaller distal airspace (L) 
compared to control lungs.  
(M and N) The sacculation defects are further demonstrated by whole mount 
staining of Aqp5 at E18.5 and a subsequent 3D reconstruction of airway surface 
(red marks Aqp5 staining and blue marks nuclei).  
Ctrl=Control; KO= Shhcre:Hdac3f/f. Two tail student's t test: *p<0.05; **p<0.01. 
Quantification data are represented as mean ± SD. Scale bars: D and J=100µm; 
N=50µm.  
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Figure 3.2: Hdac3 does not regulate lung sacculation through modulating 
cell proliferation or survival 
 
  
Control
c-
C
as
pa
se
3
Control
E16.5
N
kx
2.
1/
pH
3
E18.5
N
kx
2.
1/
B
rd
U
E18.5
A B
C D
G H
E16.5
I J
0 
0.5 
1 
1.5 
Ctrl KO 
E18.5 Epithelial 
BrdU %E
0 
1 
2 
3 
Ctrl KO 
E16.5 Epithelial 
pH3 %
F
NS
NS
Shhcre:Hdac3f/f
Shhcre:Hdac3f/f
	   105	  
Figure 3.2: Hdac3 does not regulate lung sacculation through modulating 
cell proliferation or survival 
(A-F) Assessment of cell proliferation by BrdU incorporation at E18.5 and 
phospho-histone H3 staining at E16.5 reveals no significant changes in epithelial 
cell proliferation in the Shhcre:Hdac3f/f mutant lungs. 
(G-J) Assessment of cell survival by cleaved-Caspase 3 staining shows no 
significant difference in cell apoptosis in the Shhcre:Hdac3f/f mutant lungs. 
Ctrl=Control; KO= Shhcre:Hdac3f/f. Two tail student's t test: NS=not significant. 
n=3. Quantification data are represented as mean ± SD. Scale Bars: 100µm. 
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Figure 3.3: Hdac3 is dispensible for epithelial lineage differentiation during 
lung sacculation 
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Figure 3.3: Hdac3 is dispensible for epithelial lineage differentiation during 
lung sacculation 
(A) qPCR analysis on multiple proximal and distal airway epithelial differentiation 
markers shows no significant difference in the Shhcre:Hdac3f/f mutant lungs, 
except Pdpn which is also expressed in the lymphatic endothelial cells and 
shows a moderate decrease. 
(B-I) Immunostaining of AT2 cell marker Sftpb (B and C), AT1 cell marker Pdpn 
(D and E), club cell marker Scgb1a1 (F and G) and ciliated cell marker TubbIV (H 
and J) shows no difference in major epithelial lineage commitment in the 
Shhcre:Hdac3f/f lungs. 
(J-M) Immunostaining of fibroblast marker Pdgfrα and vascular endothelial 
marker Pecam shows no difference in the mesenchymal cell lineage in the 
Shhcre:Hdac3f/f mutant lungs. 
(N) qPCR analysis shows that Klf2 expression is not significantly changed in the 
Shhcre:Hdac3f/f lungs. 
Ctrl=Control; KO= Shhcre:Hdac3f/f. Two tail student's t test: *p<0.05; NS=not 
significant. n=3. qPCR data are represented as mean ± SD. Scale Bars: C,G,I 
and M=100µm; E and K=50µm. 
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Figure 3.4: Hdac3 is required for proper spreading of AT1 cells during lung 
sacculation 
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Figure 3.4: Hdac3 is required for proper spreading of AT1 cells during lung 
sacculation 
(A-G) Prior to lung sacculation, Sftpc (green) is expressed in the distal airway 
progenitor cells at E16.5 (A) and becomes restricted to the AT2 cells as 
sacculation proceeds (B and C). The AT1 cell marker Aqp5 (red) is initially not 
expressed in the E16.5 distal airways (A). Aqp5 expression is first observed near 
the bronchio-alveolar junction at around E17.5 and marks the nascent AT1 cells 
that are still cuboidal at this time point (B, arrow). By E18.5, Aqp5 expression 
extends to the distal tip of the airways and shows that AT1 cells undergo 
substantial cell spreading to achieve a sheet-like morphology (C, arrow). In the 
Shhcre:Hdac3f/f mutant lungs, the expression level of Sftpc and Aqp5 are not 
affected during sacculation (D-F). However, the mutant AT1 cells exhibit a 
disruption in cell spreading as shown by Aqp5 staining at E18.5 (F, arrow). The 
luminal distance between neighboring AT1 cells (yellow dotted lines in C and F) 
is significantly decreased in the Shhcre:Hdac3f/f mutant lungs (G).  
(H) A model diagram illustrates the defects in AT1 cell spreading and distal 
airway expansion in the Shhcre:Hdac3f/f mutant lungs at E18.5 and how the 
neighboring AT1 cell-cell distances are measured.  
(I-L) The E18.5 primary lung epithelial cell culture shows that the Shhcre:Hdac3f/f 
mutant AT1 cells have a cell-intrinsic defect in spreading as marked by the 
significantly decreased area of Pdpn+ cells in the culture (I-K, arrows and dotted 
lines). The spreading ability of AT1 cells is quantified by the mean areas of 
Pdpn+ cells (L).  
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(M) A diagram shows Hdac3 promotes the spreading of nascent AT1 cells during 
lung sacculation in a cell-autonomous manner. 
Ctrl=Control; KO= Shhcre:Hdac3f/f. Two tail student's t test: *p<0.05; **p<0.01; 
n=3. Quantification data are represented as mean ± SD. Scale bars: F=50µm; 
K=100µm. 
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Figure 3.5: miR-17-92 and the miRNAs in the Dlk1-Dio3 locus are de-
repressed upon loss of Hdac3 expression in the lung epithelium 
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Figure 3.5: miR-17-92 and the miRNAs in the Dlk1-Dio3 locus are de-
repressed upon loss of Hdac3 expression in the lung epithelium 
(A) Microarray analysis reveals differential up-regulation of 62 primary miRNA 
transcripts in the E18.5 Shhcre:Hdac3f/f mutant lungs. Genomic location analysis 
of these miRNAs shows that the majority of them belong to two miRNA clusters; 
miR-17-92 and those in the Dlk1-Dio3 locus. 
(B and C) Diagram of how E18.5 lung epithelial cells are isolated by EpCAM 
antibody-conjugated Dynabeads and subject to downstream experiments such 
as qPCR analysis (B). qPCR analysis shows a great enrichment of epithelial cells 
in the EpCAM+ cell population and an enrichment of mesenchymal cells in the 
EpCAM- cells (C). 
(D and E) qPCR analysis on the mature form of miRNAs confirms the up-
regulation of most members of miR-17-92 cluster and some members of Dlk1-
Dio3 locus in the Shhcre:Hdac3f/f mutant epithelial cells (D). These miRNAs are 
not significantly changed in the mesenchymal cells of Shhcre:Hdac3f/f mutant 
lungs (E). 
Ctrl=Control; KO= Shhcre:Hdac3f/f. Two tail student's t test: *p<0.05; **p<0.01; 
NS=not significant; n=3. qPCR data are represented as mean ± SD. 
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Figure 3.6: Loss of Hdac3 causes similar transcriptome changes to miR-17-
92 overexpression 
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Figure 3.6: Loss of Hdac3 causes similar gene expression changes to miR-
17-92 overexpression 
(A and B) The transcriptomes of E18.5 Sftpc::MIR17-92 and Shhcre:Hdac3f/f lungs 
are compared by Gene Set Enrichment Analysis (GESA). Enrichment plots show 
that the ‘up-regulated gene set’ from the Sftpc::MIR17-92 microarray were 
enriched in the up-regulated genes in the Shhcre:Hdac3f/f microarray (A). The 
‘down-regulated gene set’ from the Sftpc::MIR17-92 microarray were enriched in 
the down-regulated genes in the Shhcre:Hdac3f/f microarray (B). 
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Figure 3.7: miR-17-92 and the miRNAs in the Dlk1-Dio3 locus suppress Tgf-
β signaling  
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Figure 3.7: miR-17-92 and the miRNAs in the Dlk1-Dio3 locus suppress Tgf-
β signaling  
(A) Comparison of predicted targets of miR-17-92 and miRNAs in Dlk1-Dio3 
Locus shows a total of 305 common genes targeted by both loci that are also 
differentially expressed in the Shhcre:Hdac3f/f mutant lungs. Signaling Pathway 
Impact Analysis (SPIA) on those genes identified several top candidate pathways 
including Tgf-β signaling and ECM-receptor interaction. 
(B and C) qPCR analysis shows that multiple components of Tgf-β pathway and 
genes involved in cell-ECM interaction are down-regulated in the epithelial cells 
of Shhcre:Hdac3f/f mutant lungs. 
(D-I) p-Smad2 is down-regulated in the distal portion of Shhcre:Hdac3f/f mutant 
lungs  (arrows) while remaining relatively unaffected in the proximal epithelium 
(white dotted lines). Co-staining with epithelial marker Nkx2.1 shows that p-
Smad2 is down-regulated in both distal epithelium and mesenchyme. 
Br=Bronchiole. 
Ctrl=Control; KO= Shhcre:Hdac3f/f. Two tail student's t test: *p<0.05; **p<0.01; 
NS=not significant; n=3-5. qPCR and quantification data are represented as 
mean ± SD. Scale Bar: I=100µm. 
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Figure 3.8: Inhibition of Tgf-β signaling results in defects in lung 
sacculation and AT1 cell spreading 
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Figure 3.8: Inhibition of Tgf-β signaling results in defects in lung 
sacculation and AT1 cell spreading 
(A-I) Treatment of TgfβRI inhibitor SB431542 on E16.5 lung explants for 48hrs 
disrupts lung sacculation (A and B) which mimics the Shhcre:Hdac3f/f mutant 
explants cultured in parallel (C). Tgf-β inhibition also leads to a defect in AT1 cell 
spreading as shown by Aqp5 staining (D-F, arrows). The defects in saccular 
formation and AT1 cell spreading are quantified, which shows significant 
alteration under SB431542 treatment (G-I). 
(J-L) Treatment of TgfβRI inhibitor SB431542 reduces AT1 cell spreading in the 
E18.5 lung epithelial cell culture. Dotted lines in S and T outline the Pdpn+ AT1 
cells. 
(M) A diagram shows that Tgf-β signaling promotes the spreading and expansion 
of AT1 cells during lung sacculation. 
Ctrl=Control; Two tail student's t test: *p<0.05; **p<0.01; NS=not significant; n=3-
5. qPCR and quantification data are represented as mean ± SD. Scale Bars: C 
and K=100µm; F=25µm. 
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Figure 3.9: Shhcre:Hdac3f/f or Shhcre:R26MIR17-92  lungs have no changes in 
Sox2+ or Sox9+ epithelial progenitor cells 
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Figure 3.9: Shhcre:Hdac3f/f or Shhcre:R26MIR17-92  lungs have no changes in 
Sox2+ or Sox9+ epithelial progenitor cells 
(A-D) Immunostaining for Sox9 expression shows that distal lung progenitor cells 
are not altered in Shhcre:Hdac3f/f mutant lungs at E16.5 or E18.5.  
(E) qPCR analysis shows that miR-17-92 miRNA expression levels are elevated 
in the Shhcre:R26MIR17-92 lung epithelial cells by a similar amount to those of 
Shhcre:Hdac3f/f mutant lungs. 
(F) qPCR analysis shows that MLE12 cells infected by lentivirus over-expressing 
miR-17-92 have a significant reduction in Tgf-β pathway components and genes 
involved in cell-ECM interaction. 
(G and H) Proximal epithelial progenitor marker Sox2 expression is not changed 
in the Shhcre:Hdac3f/f mutant lungs. 
(I-L) Sox2 and Sox9 expressions are not changed in the Shhcre:R26MIR17-92 lungs. 
Ctrl=Control; miR O/E= Shhcre:R26MIR17-92. Two tail student's t test: *p<0.05; 
**p<0.01; n=3. qPCR data are represented as mean ± SD. Scale Bars: 100µm. 
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Figure 3.10: Over-expression of miR-17-92 can phenocopy the loss of 
Hdac3 and lead to defective AT1 cell spreading and lung sacculation 
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Figure 3.10: Over-expression of miR-17-92 can phenocopy the loss of 
Hdac3 and lead to defective AT1 cell spreading and lung sacculation 
(A-F) E18.5 Shhcre:R26MIR17-92 lungs display defective sacculation that is 
characterized by increased alveolar wall thickness and narrowed distal airway 
lumens, similar to the Shhcre:Hdac3f/f mutant Lungs. 
(G-H) Quantification of alveolar wall thickness and distal airway size in control 
and  Shhcre:R26MIR17-92 lungs.  
(I-K) Double staining of Sftpc and Aqp5 shows that while AT2 cells are not 
altered, AT1 cells demonstrate reduced spreading in Shhcre:R26MIR17-92 lungs at 
E18.5 (I and J, yellow dotted line). This defect is evidenced by a decrease in the 
luminal distance between two neighboring AT1 cells (K). 
(L and M) qPCR analysis indicates that multiple components of Tgf-β pathway as 
well as genes involved in cell-ECM interaction are decreased specifically in the 
epithelial cells of Shhcre:R26MIR17-92 lungs at E18.5. 
Ctrl=Control; miR O/E= Shhcre:R26MIR17-92. Two tail student's t test: *p<0.05; 
**p<0.01; NS=not significant; n=3. qPCR and quantification data are represented 
as mean ± SD. Scale Bars: F=100µm; J=50µm. 
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Figure 3.11: Loss of epithelial miR-17-92 alleviates the defects of lung 
sacculation and AT1 cell spreading in the Shhcre:Hdac3f/f mutant Lungs 
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Figure 3.11: Loss of epithelial miR-17-92 alleviates the defects of lung 
sacculation and AT1 cell spreading in the Shhcre:Hdac3f/f mutant Lungs 
(A-H) H&E staining shows that the sacculation defects at E18.5 are alleviated in 
Shhcre:Hdac3f/f:MIR17-92f/f lungs compared to Shhcre:Hdac3f/f lungs. 
(I-J) Quantification of alveolar wall thickness and distal airway area indicates that 
these indices are significantly restored in Shhcre:Hdac3f/f:MIR17-92f/f lungs at 
E18.5. 
(K-N) Aqp5 immunostaining (red) and quantification of luminal distance (yellow 
dotted line) between two neighboring AT1 cells show that the defect in AT1 cell 
spreading is significantly improved in Shhcre:Hdac3f/f:MIR17-92f/f lungs compared 
to Shhcre:Hdac3f/f lungs at E18.5. 
Ctrl=Control; KO= Shhcre:Hdac3f/f; Rescue= Shhcre:Hdac3f/f:MIR17-92f/f. Two tail 
student's t test: *p<0.05; **p<0.01; n=3-4. Quantification data are represented as 
mean ± SD. Scale Bars: H=100µm; M=50µm. 
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Figure 3.12: Loss of epithelial miR-17-92 significantly restores Tgf-β 
pathway in the Shhcre:Hdac3f/f mutant Lungs 
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Figure 3.12: Loss of epithelial miR-17-92 significantly restores Tgf-β 
pathway in the Shhcre:Hdac3f/f mutant Lungs 
(A and B) qPCR analysis shows that multiple components of Tgf-β pathway and 
genes involved in cell-ECM interaction are significantly restored in the E18.5 
Shhcre:Hdac3f/f:MIR17-92f/f lungs compared to Shhcre:Hdac3f/f lungs. 
(C-K) p-Smad2 staining level is improved in the distal region of E18.5 
Shhcre:Hdac3f/f:MIR17-92f/f lungs compared to Shhcre:Hdac3f/f lungs. Nkx2.1 co-
staining shows that p-Smad2 level is improved in both distal epithelium and 
mesenchyme. Dotted lines mark the proximal airways. Br=Bronchiole.  
(L) A model diagram summarizes the molecular and cellular mechanisms by 
which epithelial Hdac3 regulates mouse lung sacculation. Hdac3 directs lung 
sacculation and AT1 cell spreading through suppressing miRNAs including miR-
17-92, which in turn allow for proper level of Tgf-β signaling and expression of 
cell-ECM genes that are crucial for cell spreading and tissue morphogenesis.    
Ctrl=Control; KO= Shhcre:Hdac3f/f; Rescue= Shhcre:Hdac3f/f:MIR17-92f/f. Two tail 
student's t test: *p<0.05; **p<0.01; n=3-4. qPCR data are represented as mean ± 
SD. Scale Bars: K=100µm. 
  
	   127	  
Figure 3.13: Effects of Hdac3 in adult lung bleomycin injury model 
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Figure 3.13: Effects of Hdac3 in adult lung bleomycin injury model 
(A-F) H&E staining shows that fibrotic areas are reduced in the 
SftpcCreER;Hdac3f/f mutant lungs 3 weeks after bleomycin injury. 
(G-I) Aqp5 staining shows that a significant amount AT1 cells are cuboidal like 
and less flattened in the SftpcCreER;Hdac3f/f mutant lungs after bleomycin injury 
(arrows in I). 
Scale bars: F=50µm; I=20µm. 
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Chapter 4: Future Directions 
Mouse lung development is a complicated process consisting of many distinct 
stages. In my dissertation, I have extensively interrogated the question of 
whether three members of the class I HDAC family, HDAC1, 2, and 3 are 
functionally important for lung epithelial development and regeneration by 
carefully analyzing a series of mouse genetic models. These studies revealed 
distinct roles for different members of HDACs: Hdac1/2 are redundantly required 
for the early development of proximal lung epithelial progenitor cells (refer to 
Chapter 2), while Hdac3 is required for the proper formation of primitive alveolar 
saccules and remodeling of alveolar epithelial lineages right before birth (refer to 
Chapter 3). These results are consistent with the fact that Hdac1/2 are found in 
the same chromatin remodeling complexes whereas Hdac3 resides in different 
chromatin complexes. In this chapter, I will discuss several unresolved questions 
and the potential ways to address them.  
 
What roles do class I HDACs play in lung mesodermal development? 
The data presented in Chapter 2 and Chapter 3 have described how Hdac1/2 
and Hdac3 directs lung epithelial development and regeneration. Since these 
HDAC proteins also appear to be highly expressed in the lung mesenchyme (as 
shown in Figure 2.1 and 3.1), it is possible that they are also crucial for lung 
mesodermal development.  
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To determine in which mesenchymal lineages these HDACs are expressed, we 
could double stain HDACs with various mesodermal markers, including 
endothelial marker CD31, pericyte markers Pdgfrα and Pdgfrβ and smooth 
muscle markers SM22. These data will inform us the contribution of class I 
HDACs to the development of mesodermal lineages. 
 
To study whether class I HDACs are required for the development of lung 
mesenchyme, we will utilize the Dermo1Cre line which has been shown to be 
active in various lung mesenchymal lineages (115), and cross it with Hdac1flox, 
Hdac2flox, Hdac3flox alleles. Histological sections on the lungs of Dermo1Cre : 
Hdac1/2f/f and Dermo1Cre : Hdac3f/f lungs from different embryonic stages will be 
examined for lung developmental defects. Based on the defects, we can further 
investigate the phenotype by immunostaining or qPCR for markers of cell 
proliferation, apoptosis and various lung lineages. RNA-seq or microarray can be 
performed to further understand the molecular pathways that underlie these 
phenotypes. These studies are currently underway in our laboratory. 
 
One caveat is that Dermo1Cre line is also widely active in the mesenchymal cells 
of other organs, such as in the heart. Thus Dermo1Cre : Hdac1/2f/f and Dermo1Cre : 
Hdac3f/f embryos might have a lethal heart defect that might preclude study of 
lung development. In this case, individual tamoxifen-inducible lineage deleters 
such as Tbx4creERT2 and Tie2CreERT2 (116, 117), can be used to study the function 
of HDACs in lung mesodermal development.  
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Does Tgf-β  signaling play an epithelial cell-specific role in promoting AT1 
cell spreading and lung sacculation? 
As shown in Chapter 3, pharmacological inhibition of Tgf-β signaling reduced the 
spreading area of AT1 cells in primary culture, suggesting that Tgf-β signaling 
may play a role in promoting AT1 cell spreading in a cell-autonomous manner. 
However, p-Smad2 staining was decreased in both lung epithelial cell and 
mesenchymal cells in the Shhcre:Hdac3f/f mutants. Although our data showed that 
the Shhcre:Hdac3f/f mutant AT1 cells have a cell-intrinsic defect in spreading, it is 
still unclear if a reduction of Tgf-β activity in the mesenchymal cells has any 
contributions to the phenotype seen in the Shhcre:Hdac3f/f mutants. To address 
this question, we could utilize the Alk5flox (Tgfβr1flox) allele (25) and cross it into 
the lung epithelial and mesenchymal specific deleters including Shhcre and 
Dermo1cre (or Tbx4CreERT2), respectively. We can then assess if the Shhcre:Alk5f/f 
or Dermo1cre:Alk5f/f lungs exhibit defects in lung sacculation and AT1 cell 
spreading similar to Shhcre:Hdac3f/f mutants. These data will inform us more 
definitively whether Tgf-β signaling is important for lung sacculation and in which 
cell lineages it is important.  	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Can AT1 cells exert a mechanical force to actively drive lung sacculation 
and alveologenesis? 
AT1 cells are extremely thin and spread over an extensive surface area to cover 
95% of the alveolar respiratory surface of a mature lung. They are an integral 
part of the thin interface that mediates the efficient diffusion of oxygen into the 
pulmonary capillaries. My studies presented in Chapter 3 suggest that Hdac3 
plays a critical role in promoting the spreading and remodeling of AT1 cells 
during saccular formation. One interesting phenomenon we observed during lung 
sacculation is the simultaneous occurrence of AT1 cell spreading and expansion 
of distal airspace, which raises the question whether the spreading of AT1 cells 
can exert a mechanical force to contribute to the expansion of distal airways.   
 
To address this question, we will utilize traction force microscopy (TFM) to 
measure the force exerted by the primary Pdpn+ EpCAM+ AT1 cells to the 
substrate in culture. Previous studies have suggested that interstitial fibroblasts 
play a crucial role in driving the formation of primary and secondary alveoli (118).  
We could measure the force between the Pdgfrα+ lung fibroblasts and substrate 
in parallel and compare to that exerted by the AT1 cells. Given that the ShhCre : 
Hdac3f/f AT1 cells have defects in spreading in culture, we will perform TFM on 
these mutant cell and test if they display a lack of the capacity to exert force on 
the substrate. In addition, if the Shhcre:Alk5f/f mutant lungs also have defects in 
AT1 cell spreading in vivo, we could also perform TFM on the Shhcre:Alk5f/f 
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mutant AT1 cells in culture to test if epithelial specific loss of Tgf-β signaling can 
lead to a defect in force-generating ability. 
 
Does Hdac3 play a role in the regeneration of new alveoli after lung injury? 
In Chapter 3, I have demonstrated that Hdac3 mediated repression of miR-17-92 
and subsequent Tgf-β activation is required for the proper spreading of AT1 cells 
and distal airspace during late lung development. Previous studies have 
established a well-known role for Tgf-β signaling in promoting lung fibrosis (105). 
Thus, it is possible that Hdac3 might also play an important role in promoting 
lung fibrosis given its link to Tgf-β signaling during lung development.  
 
Our preliminary data using the SftpcCreER;Hdac3f/f mutant mice showed that these 
mice had no gross lung phenotype during homeostasis. However, these mutant 
lungs exhibited a significantly reduced fibrotic response to bleomycin injury, 
suggesting that the Hdac3-miR-17-92-Tgf-β molecular cascade may also play a 
role during adult injury repair. Interestingly, staining for the AT1 cell marker Aqp5 
showed that the SftpcCreER;Hdac3f/f mutant AT1 cells displayed a more cuboidal 
and less flattened morphology, consistent with what we have observed with 
ShhCre : Hdac3f/f lungs during the developmental stage.  
 
For future studies, we will try to confirm the down-regulation of Tgf-β signaling in 
the SftpcCreER;Hdac3f/f mutant lungs by p-Smad2 staining. We should also 
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confirm whether the newly regenerated SftpcCreER;Hdac3f/f mutant AT1 cells are 
defective in spreading after bleomycin injury by testing more animals, or perform 
TFM on these mutant AT1 cell culture to see if they have an impaired ability to 
generate a mechanical force.  
 
An interesting phenotype exhibited by the SftpcCreER;Hdac3f/f mutant mice was 
that they showed both a resistance to fibrotic response and a defect in AT1 cell 
spreading. If Tgf-β signaling is confirmed to be reduced in these mutant lungs, 
then there would arise an intriguing question of how exactly this pathway 
functions during lung injury repair. It is possible that activation of Tgf-β signaling 
is important for the proper spreading of AT1 cells and regeneration of new alveoli 
after injuries. On the other hand, excessive Tgf-β signaling promotes the 
activation of fibroblasts and collagen deposition, leading to the deleterious 
fibrosis that would disrupts alveoli function. In this case, it might suggest that Tgf-
β signaling has both a positive and a negative impact on the regenerative 
process, which should be taken into consideration when we use Tgf-β inhibitors 
to treat pulmonary fibrosis. 
 
Concluding Remarks 
In this dissertation, I have investigated the functional roles of three members of 
class I HDAC family during lung development and regeneration. In Chapter 2, I 
showed that Hdac1/2 are redundantly required for the development and 
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regeneration of Sox2+ proximal lung endoderm progenitors via direct repression 
of Bmp4 and cell cycle inhibitors including Rb1/p21/p16. In Chapter 3, I 
demonstrated that Hdac3 plays a critical role in promoting alveolar epithelial 
remodeling and distal airway expansion during lung sacculation and 
alveologenesis. These studies provide some of the first evidences that lung 
development and regeneration is regulated by chromatin remodeling factors, and 
that distinct epigenetic factors can play very different physiological roles. These 
studies also provide evidence suggesting that deregulated HDAC activity can 
contribute to the pathogenesis of adult lung diseases such as COPD, and it will 
be exciting to see if these studies and future findings translate into potential 
therapies for human diseases. 
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